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ABSTRACT 
 
 
 
Peripheral infection stimulates the innate immune system to produce pro-inflammatory 
cytokines, such as tumor-necrosis-factor-α, interleukin-1β, and interleukin-6, which signal 
through various communication pathways to induce a ‘mirror image’ of cytokine expression 
within the brain. Centrally, these pro-inflammatory cytokines act directly or indirectly on 
neurons and supporting cells to alter autonomic nervous system output, endocrine system output, 
and behavior to regulate the body’s response to infection. One host factor affecting the 
behavioral response to infection is aging. Due to microglia priming and exacerbated 
neuroinflammation, aged individuals exhibit prolonged sickness behavior and depressive-like 
behavior following activation of the immune system.  Regular moderate intensity exercise has 
been show to exert neuroprotective effects that may protect against inappropriate 
neuroinflammation and behavioral disturbances in aged subjects. The purpose of these studies 
was to investigate the effects of voluntary wheel running and forced treadmill running on 
lipopolysaccharide (LPS) and Bacillus Calmette-Guérin (BCG) induced sickness behavior (food 
intake, fluid intake, body weight, locomotor activity), depressive-like behavior (tail suspension 
test, sucrose preference), and activation of brain cytokine signaling pathways in young adult and 
aged mice.  We hypothesized voluntary wheel running prior to LPS administration would induce 
anti-inflammatory effects and attenuate LPS-induced sickness behavior and depressive-like 
behavior. In contrast, we hypothesized forced treadmill exercise following BCG inoculation 
would exacerbate BCG-induced sickness behavior. 
Voluntary wheel running induced expected adaptations including body weight loss, fat 
loss, and improved forced exercise tolerance. However, voluntary wheel running did not protect 
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against LPS-induced sickness behavior, depressive-like behavior, or whole brain 
proinflammatory cytokine and indoleamine 2,3-dioxygenase gene expression in young adult and 
aged mice. Forced treadmill running following BCG inoculation caused protracted recovery from 
infection as evidenced by prolonged body weight loss, reduced voluntary wheel running, and a 
tendency for reduced sucrose preference.  
Thus, while exercise has been shown to be neuroprotective and anti-inflammatory, we did 
not observe that in our model.  Possible explanations for the deviance include: inflammatory 
model, timing of exercise in relation to immune challenge, and brain regions responsible for 
behavioral response. Future research is necessary to understand the effects of exercise on 
microglia priming and how this affects behavioral outcomes. Finally, translational research 
should investigate the effects of regular exercise training prior to, and after infection, on 
perceived sickness behaviors and depression progression in aged adults.   
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Significance 
 
Aging of the population and the increased prevalence of chronic diseases among the 
elderly are major challenges facing our society and medical community. Indeed, by the year 
2030, twenty percent of the United States population will be at least 65 years old, and the 
financial burden of age-related chronic diseases will approach 70% of national healthcare 
expenditures [1].  Many of these chronic diseases (e.g. cancer, cardiovascular disease, dementia, 
type 2 diabetes), are associated with inflammation as a key component of their pathophysiology.  
Of particular importance is the role of age-related neuroinflammation in the etiology of 
behavioral abnormalities following physiological (e.g. immune stimulus) or psychological (e.g. 
stress) challenge.  Aged animals, compared to young animals, display protracted sickness 
behavior, depressive-like behavior, and more severe cognitive impairment after stimulation of 
the innate immune system, and this is related to an exaggerated and prolonged induction of brain 
cytokine signaling pathways [1-3].  These observations have been corroborated in elderly 
humans, who following bacterial or viral infection, exhibit delayed recovery, elevated rates of 
depression, and prolonged cognitive impairment compared to younger subjects [4-6].  
Studies within the past few years have implicated microglia cells and the enzyme 
indoleamine 2,3, dioxygenase (IDO) as the primary cellular and molecular mediators of 
inflammation-induced sickness and depressive-like behavior in aged mice [7, 8]. Aged 
microglial cells exhibit increased sensitivity to stimulation, and upon activation demonstrate 
elevated production of proinflammatory cytokines (TNFα, IL-1β, IL-6) [8]. In addition to 
inducing sickness behavior, these proinflammatory cytokines activate IDO leading to the 
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synthesis of several neurotoxic metabolites implicated in the pathophysiology of inflammation 
induced depressive-like behavior [7].   
From a clinical perspective, prolonged sickness behavior and increased depressive 
symptoms result in a reduction in self care, loss of independence, and are often the first steps 
towards dependent living in elderly individuals.  Additionally, depression in elderly subjects is 
associated with an elevated risk for all cause morbidity and mortality [9].  The current protocol 
for treating age-related depression involves antidepressant therapy, which is moderately 
effective, but does not address the underlying inflammatory pathophysiology.  Thus, there 
continues to be a major need to identify safe, alternative approaches for treating depression and 
reducing inappropriate neuroinflammation in the elderly. 
Regular cardiovascular exercise may be one approach to alleviate age-related 
inflammation-based behavioral disturbances, as numerous studies have reported exercise-
induced reductions in systemic and tissue specific inflammation [10]. In regard to age-related 
neuroinflammation, Barrientos et al. demonstrated voluntary wheel running (VWR) reduced 
microglia priming, proinflammatory cytokine induction, and cognitive impairment following 
E.coli infection in aged rats [11]. No studies, however, have examined the effects of exercise 
training on inflammation induced sickness behavior and depressive-like behavior in aged mice.   
Therefore, the goal of the following specific aims is to determine if/how exercise training 
prior to or after immune stimulus can attenuate sickness behavior and depressive-like behavior in 
mice.  Results from these studies may be clinically useful to prescribe prevention and treatment 
regimens to improve behavioral outcomes following infection in aged adults. 
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1.2 Specific Aims 
This study, the first to examine the role of exercise training on sickness behavior and 
depressive-like behavior, has three specific aims. These are presented below. Methods, 
hypotheses, expected results, and alternative hypotheses are presented briefly. A full description 
of the study methodology, including experimental design and statistical analysis, can be found in 
Chapter 3. 
 
1.2.1 Specific Aim #1 
Does voluntary wheel running attenuate the exaggerated and prolonged sickness 
behavior observed in aged mice in response to acute LPS-induced inflammation? And, if so, 
is this effect associated with reduced peripheral and brain proinflammatory cytokine gene 
expression? 
Twenty-two month old male C57bl/6 mice from the NIA Aging Colony were randomized 
to three housing conditions (Wheel, Locked Wheel, and Shoebox) for a duration of ten weeks. 
The purpose of the locked wheel and shoebox cages is to control for environmental enrichment 
created by the running wheel. Following ten weeks of housing intervention, all mice were placed 
in shoebox cages 24h prior to intraperitoneal (i.p.) injection of lipopolysaccharide (LPS) or 
equivolume sterile saline. The purpose of placing all mice in shoebox cages is to control for any 
acute exercise prior to or following LPS treatment; the specific goal of this study is to determine 
the effects of voluntary exercise training on LPS induced sickness behavior and inflammation.  
LPS will be injected at four different doses (0.33 mg/kg, 0.16 mg/kg, 0.08 mg/kg, and 0.02 
mg/kg). The purpose of the different LPS doses is to ascertain whether potential exercise-
induced effects occurred in a dose-dependent manner. This range of LPS doses was selected 
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based upon previous studies demonstrating that 0.33mg/kg LPS produced prolonged sickness 
behavior in aged, compared to young mice [2], and 0.02mg/kg being the lowest dose capable of 
inducing statistically significant changes in sickness behaviors when compared to saline treated 
mice.  
Body weight, food intake, fluid intake, and locomotor activity will be collected at 8h, 24, 
48h, and 72h post-injection.  
Another set of mice will undergo identical intervention conditions and injections, but will 
be sacrificed at 24h post-injection for tissue collection.  This time-point was determined based on 
previous data from our lab.  Whole brain, liver, and spleen, will be dissected and rapidly frozen 
for quantification of proinflammatory gene expression. 
With the lower doses LPS (0.02 mg/kg, 0.08 mg/kg, and 0.16mg/kg), it is hypothesized 
there will be a housing intervention dose-response in regard to sickness behavior attenuation and 
proinflammatory cytokine reduction. That is, VWR will exhibit the greatest attenuation, followed 
by locked wheel, and shoebox. In contrast, however, we expect to see no beneficial effects of 
VWR or LW at higher dose LPS (0.33 mg/kg), as this magnitude of inflammation most likely 
abolishes any exercise or environmental enrichment-induced anti-inflammatory adaptations.  
These hypotheses are based off Barrientos et. al’s data demonstrating wheel training reduces 
microglial priming and inflammation induced pro-inflammatory cytokine production in aged 
rats. 
Alternatively, should exercise exert no beneficial effects on sickness behavior or brain 
inflammation in aged mice, it suggests that an appropriate sickness response may be critical for 
organism survival and cannot be altered by exercise training. 
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1.2.2 Specific Aim #2  
Does voluntary wheel running attenuate sickness behavior and depressive-like 
behavior observed in young adult compared to aged mice in response to acute LPS-induced 
inflammation? And, if so, is this effect associated with reduced brain proinflammatory 
cytokine and IDO gene expression? 
Experiment 1: Sixteen week-old male C57bl/6 mice from the Jackson Labs will be 
randomized to two housing conditions (Wheel or Shoebox) for a duration of thirty days.  
Following the housing intervention, mice will be intraperitoneally inoculated with 0.83 mg/kg 
LPS or equivolume saline, and placed back in their respective cage conditions.  This dose of LPS 
was chosen because it produces transient sickness behavior (~12h) and depressive-like behavior 
(24h) in young adult C57bl/6J mice. Sickness behavior (body weight, food/fluid intake, 
locomotor activity) and depressive like behavior (sucrose preference and tail suspension test) 
will be assessed at 24h.  Another group of mice will undergo identical treatment and be used for 
tissue collection at 4h post-injection. This time-point was chosen on peak IDO expression 
following LPS injection in young mice [3]. Tissue analysis will include brain proinflammatory 
cytokine and IDO gene expression. 
Experiment 2: Nineteen month old male C57BL/6 mice from the NIA Aging Colony 
will be randomized to two housing conditions (Wheel or Shoebox) for a duration of seventy 
days.  Following the housing intervention, mice will be intraperitoneally inoculated with 0.33 
mg/kg LPS or equivolume saline, and placed back in their respective cage conditions.  This dose 
of LPS was chosen because it is the minimum effective dose to reliably produce depressive-like 
behavior in aged C57BL/6J mice. Sickness behavior (body weight, food/fluid intake, locomotor 
activity) and depressive-like behavior (sucrose preference and tail suspension test) will be 
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assessed at 24h (sucrose preference) and 48h (tail suspension).  Another group of mice will 
undergo identical treatment and be used for tissue collection at 24h post-injection. This time-
point was chosen based on data by Godbout et al. indicating it as the critical time-point of 
prolonged pro-inflammatory cytokine and IDO gene expression, differentiating the aged and 
young adult neuroinflammatory response. Tissue analysis will include brain proinflammatory 
cytokine and IDO gene expression. 
It is hypothesized there will be a housing intervention dose-response in regard to 
depressive-like behavior attenuation, and this will be related to a reduction in brain IDO gene 
expression in both young adult and aged mice. Furthermore, this reduction in IDO expression 
will be associated with decreased brain TNFα and IFNγ, two primary activators of IDO. These 
hypotheses are supported by Barrientos’s data demonstrating ex vivo stimulation of microglia 
from VWR trained rats exhibited significantly blunted TNFa gene expression compared to 
sedentary rats. 
Should VWR yield no beneficial behavioral or anti-inflammatory effects, it could be 
hypothesized that the sensitivity of IDO to cytokine activation is too low to be affected by 
exercise training, which has been shown to reduce, but not abolish, inflammation-induced brain 
proinflammatory cytokines.   
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1.2.3 Specific Aim #3  
Does exercise intervention after infection prevent the progression of sickness 
behavior to depressive-like disturbances in aged mice in response to chronic BCG-induced 
inflammation?  
In contrast to the prior two aims, this aim will examine whether exercise training 
following immune challenge can attenuate sickness behavior and depressive-like behavior in 
mice.  Twelve week old Balb/c mice will be intraperitoneally inoculated with either 10 
micrograms BCG or equivolume saline, and placed back into cages containing running wheels. 
This dose of BCG was chosen because it adequately allows for the dissociation of sickness 
behavior (1-5 d) and depressive-like behavior (6-8 d) in young mice. Beginning at 4                                                                                                           
h post-inoculation, mice will be treadmill run once per day for thirty minutes at an intensity of 8-
12m/m (60-70% VO2max) until the end of the study; a control group of mice will have food 
removed and be exposed to the noise of the treadmill for the same duration as the runner.  
Sickness behavior (body weight, food/fluid intake, wheel running activity) will be monitored 
from inoculation to day 5. On day 6, mice will be subjected to a sucrose preference test.   
It is hypothesized that treadmill training post-inoculation will attenuate depressive-like 
behavior as manifested by increased sucrose preference.  There is little evidence to support this 
hypothesis, but the translational yield is extremely high.  Imagine a physician prescribing 
exercise training post-infection to reduce the risk of developing depression.  
Alternatively, post-inoculation exercise training could have no beneficial effects or could 
even exacerbate inflammation- induced depressive-like behavior. In this case, it would be 
concluded that aged subjects should completely recover from infection prior to commencing 
exercise training.  
 8 
 
 
1.3 Summary 
 
The overall aim of these studies is to determine the effects of exercise training, prior to 
and proceeding immune challenge, on inflammation-induced sickness behavior and depressive-
like behavior in young and aged mice. Specifically, these experiments will address whether 
exercise training can attenuate inflammation induced behavioral abnormalities, and whether this 
is associated with reduced neuroinflammation. Results from these studies may be clinically 
useful to prescribe prevention and treatment regimens to improve behavioral outcomes following 
infection in aged adults. 
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CHAPTER 2 
 
LITERATURE REVIEW
1
 
 
 
2.1 Inflammation 
 
While inflammation has only recently garnered greater attention for its relationship to a 
variety of disease processes, the effects of inflammation have been recognized for centuries. The 
Roman physician Celsus first characterized inflammation circa 30 BC-38 AD by five cardinal 
signs: pain (dolor), heat (calor), redness (rubor), swelling (tumor), and loss of function (functio 
laesa) [12]. Since that time, scientists have come to recognize inflammation as a highly 
coordinated nonspecific innate immune response to harmful stimuli, with the principal goal of 
inflammation being the elimination of the stimuli and initiation of tissue healing. Common 
stimuli include pathogens, damaged cells, and aggregated cellular/metabolic by-products.   
 The initial step of the inflammatory response is recognition of the inflammatory 
stimulus. Sentinel cells located throughout the body (e.g., circulating monocytes, tissue 
macrophages, and tissue dendritic cells) constantly monitor circulating fluids and tissues for the 
presence of pathogens [12].  Pathogen recognition by these cells is mediated by several classes of 
receptors referred to as pattern-recognition receptors (PRRs). Unlike most cellular receptors that 
recognize a unique ligand, PRRs recognize classes of molecules termed pathogen-associated 
molecular patterns (PAMPS). The most widely studied PRRs are Toll-like receptors (TLRs), 
which have evolved to recognize proteins, lipids, and unmodified nucleic acid molecules found 
on infectious pathogens. TLRs are located either within the cell membrane or in 
endosomes/lysosomes, and the cellular location depends on whether or not the specific TLR 
                                                        
1 This chapter contains three previously published figures that were not created by the author. The author has received 
reprint permission from the copyright owners.  
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recognizes extracellular pathogens (e.g., bacterial components) or intracellular pathogens (e.g., 
viral components). Ligand binding of most TLRs induces signal transduction through myeloid 
differentiation primary response gene 88 (MyD88), which acts as an adaptor protein and initiates 
a mitogen-activated protein kinase. This process ultimately terminates with the transcriptional 
factor nuclear factor kappa beta (NF-κB) binding DNA and initiating transcription of pro-
inflammatory cytokines, such as TNFα, interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and 
interferon gamma (IFNγ) [13].  The expression of cytokines by macrophages and dendritic cells 
then recruits other cells of the immune system to the site of infection/damage to clear the 
pathogen and begin tissue repair.     
 
2.2 Communication between Immune System and Brain 
 
For years, the brain was considered an “immune-privileged” organ in which the blood 
brain barrier prevented the influx of large proteins (e.g., cytokines) and cells (e.g., macrophages). 
However, within the past thirty years, studies have shown that proinflammatory cytokines act not 
only locally at the site of infection but also centrally in the brain to induce behavioral changes 
that promote organism recovery and survival from infection. This discovery was based on the 
observation that intraperitoneal (i.p.) administration of lipopolysaccharide (LPS) induced 
upregulation of brain proinflammatory cytokine proteins (e.g., I-1β and TNFα) and concurrent 
sickness behavior [14, 15]. Central administration of IL-1 receptor antagonist (IL-1Ra) and 
TNFα soluble receptor 1 (TNFαSR1) was shown to abolish the peripherally induced upregulation 
of brain IL-1β, TNFα, and sickness behavior, experimentally proving the existence of immune-
to-brain communication [16-18]. It is now well understood that peripheral infection stimulates 
the innate immune system to produce pro-inflammatory cytokines, such as IL-1β, TNFα, and IL-
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6, which signal through various communication pathways to induce a ‘mirror image’ of cytokine 
expression within the brain. Centrally, these pro-inflammatory cytokines act directly or indirectly 
on neurons and supporting cells (e.g., microglia and astrocytes) to alter autonomic nervous and 
endocrine system output to regulate the body’s response to infection. The brain monitors 
peripheral inflammatory responses via four primary communication mechanisms, which are 
briefly explained below and demonstrated in Figure 1. 
The initial and fastest route of communication is through the afferent nerves. Locally 
produced cytokines, in particular IL-1β, bind IL-1 Receptor (IL-1R) on afferent vagal nerves 
during visceral infections and trigeminal nerves during oro-lingual infections [15, 19]. Upon IL-
1β binding, the afferent nerves transduce a signal through the nucleus tractus solaris in the brain 
stem to secondary projections in the parabrachial nucleus and from there to the hypothalamus 
and hippocampus [15, 19]. Activation of this neural pathway sensitizes the target brain structures 
for the action of cytokines propagated via other communication routes and initiates the 
hypothalamic-pituitary-adrenal (HPA) axis response to inflammation [20]. Bluthe et al. 
experimentally proved the vagal pathway by demonstrating that a subdiaphragmatic vagotomy 
attenuated the brain proinflammatory cytokine response and sickness behavior induced by 
peripheral inflammation [21-23]. These changes were correlated with reduced c-fos activity in 
the limbic structures and the ventromedial preoptic area, structures known to mediate certain 
aspects of sickness behavior. c-Fos belongs to the immediate early gene family of transcription 
factors; expression of c-fos is an indirect marker of neuronal activity, as c-fos is upregulated 
when neurons initiate action potentials [24]. Interestingly, vagotomized mice still develop i.p. 
LPS-induced fever, HPA axis activation, and intravenous (i.v.)-induced sickness behavior, 
indicating neural communication is not required for all components of sickness behavior, and 
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different pathways mediate sickness behavior based on the infection location/route of delivery 
[21-23]. 
In contrast to the rapid activation of the neural pathway, three humoral pathways allow 
communication between the immune system and the brain during peripheral infection: diffusion 
across circumventricular organs (CVOs), saturable transporters, and secondary messenger 
signaling. The majority of the blood brain barrier (BBB) is composed of cellular tight junctions 
that prevent the passage of large proteins, such as cytokines. However, specific brain regions, 
such as the circumventricular organs and the subfornical organ, contain ‘leaky’ fenestrated 
capillaries, which allow diffusion of molecules across the BBB [25]. Blatteis et al. first 
demonstrated this phenomena by lesioning a CVO located adjacent to the hypothalamic 
thermoregulatory mechanism and observing a cytokine induced fever [26]. Further studies have 
confirmed this finding, and it is now well recognized that upon peripheral infection, circulating 
cytokines and cytokines synthesized  by ‘macrophage like cells’ located within the CVOs cross 
the BBB, bind their respective receptors, and propagate signals to brain regions that regulate the 
sickness response (e.g., the hypothalamus) [25].  
Following the discovery that cytokines cross the BBB, a second humoral route of 
peripheral-to-brain communication was elucidated. Banks et al. elegantly demonstrated the 
existence of saturable transporters that actively transport IL-1β, TNFα, and IL-6 across the BBB. 
The subsequent antagonism of these transporters following i.v. IL-1β administration reduced the 
central expression of proinflammatory cytokines and protected against inflammation induced 
behavioral impairments [25, 27, 28]. Recent work indicates these transporters are not static but, 
instead tightly regulate cytokine transport based on the age of the organism, circadian rhythm, 
central nervous system (CNS) region, and disease state [25].  
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The final humoral communication pathway occurs through a second messenger system in 
the endothelial cells lining the BBB, which express receptors for IL-1β, TNFα, and IL-6. Ligand 
binding activates the enzyme cyclooxygenase, resulting in prostaglandin E2 (PGE2) and nitric 
oxide synthesis and subsequent diffusion across the BBB [15, 25, 29, 30]. Upon crossing the 
brain parenchyma, PGE2 acts on receptors (EP3 and EP4) in the brainstem and hypothalamus to 
regulate the HPA axis and pyrogenic response to inflammatory stimuli. The synthesis of PGE2 is 
dependent on cyclooxygenase 2 (COX2) and prostaglandin synthesizing enzymes, both of which 
are highly expressed in the endothelial cells of cerebral blood vessels; pretreatment with specific 
COX2 inhibitors abrogates the LPS induced fever and HPA axis response [30].   
Regardless of the immune-to-brain communication route, once an inflammatory signal is 
propagated, brain microglia cells become activated and commence de novo proinflammatory 
cytokine production. The molecular and cellular mechanisms responsible for de novo microglia 
cytokine production are not well characterized, but as mentioned earlier, this central response 
creates a mirror image of the periphery to promote an appropriate behavioral response.  
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Figure 1. Parallel communication routes between the immune system and brain. The neural 
pathway involves rapid communication of immune signals via primary afferent nerves. For 
instance, peripherally produced cytokines directly stimulate vagal afferents from the liver to 
elicit central responses. In the diffusion pathway, blood-derived cytokines passively traverse the 
blood-brain barrier at “leaky” brain regions, including the circumventricular organs. 
Transportation of peripheral cytokines occurs by an energy-dependent, saturable process 
involving transporters integral in the blood-brain barrier. A fourth route of communication 
currently being investigated involves endothelial cells composing the blood-brain barrier. It is 
believed that circulating cytokines bind to endothelial receptors to elicit the release of immune 
molecules (e.g., cytokines, NOS, etc.) directly into brain regions. Regardless of the pathway, 
inflammatory mediators released into the CNS activate brain microglial cells to release 
inflammatory cytokines, which subsequently bind neuronal receptors in specific brain regions 
(e.g., hippocampus) to initiate the sickness behavior syndrome [31]. 
 
2.3 Sickness Behavior and Depressive-like Behavior 
Peripherally and centrally produced cytokines act directly or indirectly on neurons and 
supporting cells (e.g., microglia and astrocytes) to alter autonomic nervous and endocrine system 
output to regulate the body’s response to infection. IL-1β, for example, induces activation of the 
hypothalamic-pituitary-adrenal axis and the production of corticosteroids, which attenuate the 
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pro-inflammatory response in a negative feedback loop [32].  Moreover, these cytokines 
propagate signals to various brain structures, including the hypothalamus, hippocampus, 
amygdala, and prefrontal cortex, to invoke a constellation of motivated behavioral adaptations 
(i.e., ‘sickness behavior’). These adaptations allocate energy and resources towards the immune 
response and support recovery from infection [15]. Sickness behaviors include loss of appetite 
and body weight, fatigue, withdrawal from normal social activities, altered cognition, 
hyperalgesia, and fever [19, 33]. These non-specific symptoms were long believed to be a 
general weakness and malaise associated with infection. The importance of such behaviors, 
however, was bolstered by the powerful observation that forced tube feeding of anorexic sick 
mice to normal ad libitum levels resulted in greater mortality to Listeria monocytogenes [34]. It 
is now understood these evolutionarily conserved behaviors are essential for energy 
conservation, heat regulation, and ultimately organism survival. 
IL-1 β and TNFα are the primary drivers of inflammation induced sickness behavior. 
Peripheral or central administration of IL-1β or TNFα induces the entire spectrum of sickness 
behavior [13, 29]. The behavioral effects of IL-1β and TNFα are mediated through IL-1R1 and 
TNF-R1 expressed on neurons within the CNS [13, 15]. IL-1R1 knockout (KO) mice do not 
exhibit a sickness response to IL-1β administration, but do respond to i.p. LPS or TNFα 
injections [35, 36]. Interestingly, TNFα antibody administration to these mice abrogated LPS 
induced sickness behavior, experimentally proving the redundant pathways for IL-1β and TNFα 
for initiating inflammation induced sickness behavior [35, 36]. Exactly how IL-1β and TNFα 
alter neuron function is not entirely understood, but the following hypotheses have been 
postulated to suggest these cytokines: 1) signal through p38 and JNK within the hippocampus to 
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impair long term potentiation via inhibition of calcium signaling or 2) upregulate neuronal 
ceramide synthesis and subsequent calcium influx, resulting in neuron excitotoxicity [13].   
In contrast to IL-1β and TNFα, IL-6 and IFNγ synthesized during infections do not elicit 
sickness behavior, despite activating the fever and HPA response. Neither IL-6 nor IFNγ 
administration alone was shown to induce a sickness response [13, 36]. O’Connor et al. 
demonstrated IFNgR1 KO mice develop a normal sickness response to Bacillus Calmette–
Guérin (BCG) infection, suggesting IFNγ is not required for a sickness response [37]. Similarly, 
Bluthe et al. showed IL-6 knockout mice exhibited an attenuated, but not abrogated, sickness 
response to LPS, and exogenous administration of IL-6 restored the sickness response to wild-
type levels [38]. The lack of a complete abolishment of LPS induced sickness in IL6KO mice 
indicates rather than inducing sickness behavior, IL-6 amplifies the actions of IL-1β and TNFα 
and is necessary for the ‘full’ sickness response. 
In addition to inducing sickness behavior, peripheral inflammation can also induce major 
depressive disorders in humans and depressive-like behavior in animal models [15, 39]. Chronic 
inflammatory conditions, such as aging, atherosclerosis, and rheumatoid arthritis, are associated 
with an increased prevalence of depression (i.e., co-morbid depression), which is evidenced by a 
strong correlation between depressive behavior and circulating c-reactive protein (CRP) levels. 
Furthermore, patients undergoing cytokine immunotherapy for hepatitis and cancers exhibited an 
initial sickness response, followed by depressive episodes characterized by a depressed mood, 
guilt, and even suicidal thoughts [40, 41]. These associative observations yielded the “cytokine 
theory of depression,” which postulates that proinflammatory cytokines produced during 
immune activation alter brain neurochemistry and mediate inflammation-associated depression. 
Indeed, preclinical animal models support this theory, as activation of the peripheral innate 
 17 
 
immune system with lipopolysaccharide or BCG induced an episode of sickness behavior. The 
sickness behavior was followed by depressive-like behavior, as measured by increased 
immobility in the tail suspension test and forced swim test and decreased consumption of a 
sweetened solution, all of which can be attenuated by chronic pretreatment with anti-depressants 
[42, 43]. 
Clinical evidence suggests that altered tryptophan metabolism potentially mediates 
inflammation-associated depression. In most clinical cases of inflammation-associated 
depression, a strong correlation between depressive behavior and an increased plasma ratio of 
kynurenine to tryptophan exists, suggesting a pivotal role for the tryptophan-metabolizing 
enzyme indoleamine 2,3 dioxygenase (IDO) [41]. IDO activation shunts tryptophan metabolism 
towards the kynurenine pathway, ultimately resulting in the production of the metabolites 
kynurenic acid, quinolinic acid (QA), and 3-hydroxykynurenine (3-HK) [41]. Under basal 
conditions, IDO is expressed at low levels in microglial cells and astrocytes, with the majority of 
kynurenine activity occurring in astrocytes, and the primary end product being kynurenic acid, a 
neuroprotective N-methyl-d-aspartate (NMDA) antagonist [41]. However, during immune 
activation, the proinflammatory cytokines TNFα and IFNγ induce IDO activation in the 
periphery (spleen, lung, mononuclear cells) and microglial cells, which shifts kynurenine 
metabolism towards the production of neurotoxic metabolites 3-HK and QA, which have been 
implicated in inflammation-induced depressive-like behavior [41] (Figure 2).  Indeed, O’Connor 
et al. elegantly demonstrated IDO blockade using IDO KO mice and the nonspecific IDO 
inhibitor 1-methyltryptophan prior to LPS administration protected against LPS-induced 
depressive-like behavior [43, 44]. Furthermore, i.p. administration of L-kynurenine induced 
depressive-like behavior in a dose-dependent manner [43, 44].   
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Figure 2. Peripheral administration of lipopolysaccharide (LPS) induces sickness behaviour that 
peaks 2 to 6 hours later and gradually wanes (a). Depression-like behaviour, as measured by 
increased immobility in the forced-swim test or the tail-suspension test and decreased preference 
for a sweet solution, emerges on this background. The development of sickness behaviour 
requires activation of pro-inflammatory cytokine signaling in the brain in response to peripheral 
LPS (b). Some of the pro-inflammatory cytokines that induce sickness behaviour also enhance 
activity of the ubiquitous indoleamine 2,3 dioxygenase (IDO) that peaks at 24 hours post-LPS. 
Activation of IDO results in decreased tryptophan (TRP) levels and increased production of 
kynurenine (KYN) and other tryptophan-derived metabolites. Pre-treatment with the second-
generation tetracycline minocycline, which has potent anti-inflammatory effects both at the 
periphery and in the brain, blocks both LPS-induced sickness behaviour and depression-like 
behaviour. By contrast, administration of 1-methyl tryptophan (1-MT), a competitive inhibitor of 
IDO, blocks LPS-induced depression-like behaviour without altering LPS-induced sickness 
behaviour [39]. 
 
In conclusion, the expression of proinflammatory cytokines induces sickness behavior, 
and through IDO activation, depressive-like behavior. Understanding the mechanisms of these 
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behavioral sequelae will allow for therapy targeted toward inflammation induced behavioral 
disturbances, and in particular, the comorbid depression observed in pathological conditions, 
such as aging, cardiovascular disease, and diabetes.  
 
2.4 Aging, Microglia Priming, and Behavioral Consequences  
The depressive symptoms manifested by the cytokine responses described above have 
clinical and psychosocial implications. Depressive disorders are estimated to affect up to 50% of 
elderly patients residing in long-term care facilities, and nearly 70% of these patients reported 
feelings of depression or sadness to the extent that their quality of life was impaired [45-47]. 
While the precipitating factors involved in age-related depression are not entirely clear, 
significant clinical and experimental evidence demonstrates that neuroinflammation, as 
characterized by increased basal levels of pro-inflammatory cytokines and oxidative stress and 
reduced anti-inflammatory cytokines and growth, occurs within the brain during normal aging 
[31].  As a large majority of the population is reaching older ages, it is of interest to determine 
the causes of age-induced neuroinflammation. In fact, resident microglia cells appear to be the 
primary mediator of age-induced neuroinflammation [31].  Microglia are innate immune cells of 
the brain that play critical roles in development, plasticity, and immune surveillance, with 
essential functions, such as clearing apoptotic bodies, synaptic pruning, and responding to 
inflammatory stimuli [31, 48, 49]. Young, healthy microglia maintain a ramified morphology 
with long and thin processes that constantly survey the tissue and respond rapidly to any local 
homeostatic disturbance (Figure 3). Microglia comprise approximately 15% of human CNS cells 
and approximately 10% of rodent CNS cells; these cells are derived from the primitive yolk sac 
myeloid cells and migrate to the CNS during embryonic development, after which replication 
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and turnover is limited [50, 51]. As mentioned in the previous section, microglia are key cellular 
players of the coordinated response to infection by the peripheral immune system and the central 
nervous system; peripheral inflammatory signals are responded to and propagated by microglia, 
which then produce central pro-inflammatory cytokines, such as TNFα, IL-1β, and IL-6.   
In young healthy brains, the activation of microglia and the production of cytokines are 
transient processes, and microglia return to a quiescent state as the inflammatory stimulus is 
resolved. However, evidence in the past ten years indicates that aged microglia cells exist in a 
“primed” state with a heightened sensitivity to activation. Though controversial, the majority of 
data indicates no age-induced changes in microglia numbers [52]. However, the primed 
microglia commonly seen with aging are morphologically distinguishable by their shorter 
deramified processes and the upregulation of the inflammatory cell surface markers MHC II and 
CD11b (Figure 3) [31, 48, 53]. Additionally, primed microglia express increased steady-state 
levels of TNFα, IL-1β, and IL-6 mRNA and decreased anti-inflammatory IL-10 [54-56] . Upon 
immune activation, aged microglia respond with an exaggerated and prolonged pro-
inflammatory response. For example, isolated microglia from aged rats produced elevated levels 
of TNFα and IL-1β following LPS stimulation, and this effect occurred in an LPS dose-response 
manner [57]. Along those lines, aged mice injected intraperitoneally or centrally with LPS 
exhibited an exaggerated and prolonged peripheral and central pro-inflammatory cytokine 
response. More importantly, this exaggerated inflammatory response results in behavioral 
disturbances compared to young mice. Godbout et al. demonstrated aged mice exhibited 
protracted sickness behavior (reduced locomotor activity [LMA]) and depressive like behavior 
(increased Forced Swim Test [FST] and Tail Suspension Test [TST] immobility) compared to 
young mice following injection with LPS, and this effect was associated with elevated brain IL-
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1β and IDO gene expression and increased IDO activity [58, 59]. Kelley et al. corroborated these 
results by demonstrating an identical effect using BCG as an inducer of the chronic inflammatory 
response in aged mice [60]. In addition to sickness behavior and depressive like behavior, several 
labs have reported cognitive impairments following immune activation in aged mice. Using live 
bacteria, Barrientos et al. demonstrated that E. coli infection in aged mice induced central 
inflammation and hippocampal IL-1β upregulation, which inhibited the production of 
hippocampal brain derived neurotrophic factor (BDNF), a growth factor that drives neurogenesis 
and neuron survival and is vital for learning and memory [61-64]. This inhibition of BDNF 
results in cognitive impairment as measured by the Morris water maze, elevated plus maze, and 
contextual fear conditioning test [63, 65]. Numerous studies have experimentally implicated 
microglia as being responsible for age-induced neuroinflammation. Treatment of mice with 
minocycline, a strong anti-inflammatory agent and microglia inhibitor, attenuated LPS and BCG 
induced IL-1β, TNFα, and IL-6 in the brains of aged mice and reduced inflammation induced 
sickness behavior and depressive-like behavior [43, 44].  
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Figure 3. Microglial cells in the aged brain elicit a discordant inflammatory response upon 
activation by the peripheral innate immune system. (A) Similar to the priming paradigm 
proposed for peripheral macrophages, microglial cells in the aged brain may be primed as 
characterized by phenotypic alterations (e.g., increased expression of cell-surface markers). 
Upon receiving a triggering stimulus, these primed microglia release excessive concentrations of 
inflammatory cytokines in the CNS. (B) Evidence suggests the aged mouse brain responds to 
peripheral infection with a more exaggerated cytokine response compared with the adult mouse 
brain. Subsequent to peripheral immune stimulation with lipopolysaccharide (LPS), the release 
of IL-1β is higher in the aged vs. adult mouse brain [10]. (C) Both priming and triggering stimuli 
appear necessary to cause a discordant response by microglial cells in the aged brain. Cytokines 
released by microglia normally initiate an adaptive sickness behavior syndrome that includes 
anorexia, fever, and decreased social exploration. However, excessive cytokine release by 
primed and activated microglia elicits a discordant, maladaptive sickness behavior syndrome in 
the aged animal [31]. 
 
The mechanisms responsible for the aberrant priming of microglial cells in the aged brain 
are not entirely understood, but several studies point to the dysregulation of neuron/microglia 
cross-talk. In the non-diseased young brain, neuronal derived proteins, including fractalkine and 
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cluster of differentiation 200 (CD200), act as ligands for their respective microglial receptors and 
maintain the microglia in a quiescent/surveying state [48].  For example, fractalkine, which can 
either be neuronal membrane bound or free, binds to CX3CR on microglia and maintains the cell 
in a quiescent state. Following immune activation, fractalkine signaling is critical for attenuating 
the microglia inflammatory response and restoring brain inflammation to baseline levels. Several 
studies indicate aging reduces basal levels of fractalkine, which may partially explain microglial 
priming [48]. Furthermore, following a LPS challenge, microglia from aged mice exhibited a 
prolonged downregulation of the fractalkine receptor that may contribute to the prolonged 
proinflammatory cytokine response and protracted sickness behavior observed in aged mice [66]. 
Microglia from adult mice had restored fractalkine receptor expression 24 h post-LPS injection, 
while expression was not restored at this time-point in aged mice. Similar to fractalkine, CD200 
signaling assists in maintaining microglia in a resting state, and evidence indicates this signaling 
is impaired during aging. CD200 is a membrane glycoprotein expressed on neurons that binds its 
corresponding microglia receptor, CD200R. Evidence for the importance of CD200 in 
modulating the neuroinflammatory response comes from CD200 knockout mice, which exhibited 
a heightened neuroinflammatory response following inflammatory stimuli [67, 68]. During 
aging, CD200R is downregulated on microglia compared to adult mice, and CD200 is reduced 
on neurons [48].  Intrahippocampal injection of CD200 fusion protein or fibroblast growth loop 
(FGL, a mimetic) reduced the neuroinflammatory response in the aged mouse brain following 
LPS injection and improved inflammation associated behavioral outcomes [69].  
Aging induces morphological and phenotypical changes to microglia cells, and during an 
inflammatory challenge, the aged organism responds with exacerbated sickness behavior and 
depressive-like behavior. Therapies targeted at attenuating age-induced neuroinflammation and 
 24 
 
microglia priming are important for reducing the prevalence of behavioral disturbances in the 
rapidly aging population.   
 
2.5 Exercise, Neuroinflammation, and Behavior 
The mood enhancing benefits of cardiovascular exercise have been well documented in 
the literature and through the anecdotal testimony of thousands of exercisers. In fact, exercise 
may represent a promising approach to attenuate the negative behavior alterations induced by the 
inflammatory response. Cross-sectional studies have shown an association between a high 
amount of physical activity and a low amount of depressive symptoms in both middle-aged and 
aged populations [70, 71]. Physical exercise might be especially efficient in reducing depressive 
symptoms among patients with mild to moderate depression [71]. This finding is important 
because a large fraction of older adults (10-20%) have clinically significant depressive symptoms 
but do not meet all of the criteria for major depression [45]; exercise may be used with these 
individuals in the absence of pharmacological therapy to mitigate the depressive symptoms. 
Sjosten and Kivela (2006) reviewed published randomized clinical trials using a rigorous study 
selection scheme to determine the strength of an effect of regular exercise on depression in older 
adults [72]. Based on their review, they concluded while more well-controlled studies are 
needed, exercise was effective in treating depression among those suffering from minor or major 
depression and in reducing depressive symptoms in those with significant depressive symptoms 
at baseline. The biological mechanisms responsible for the anti-depressant effects of exercise are 
not elucidated, but evidence indicates the effects may be associated with an exercise-induced 
attenuation of systemic and neuroinflammation [73-75]. Depression is often highly correlated 
with circulating CRP levels in humans, and numerous studies have demonstrated that regular 
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exercise training reduces CRP in a variety of populations, including aged, obese, and 
cardiovascular disease patients [74, 76, 77]. Animal models have shown reduced basal brain 
mRNA expression of IL-1β, TNFα, and IL-6 in several brain regions in response to chronic 
exercise training [78-80]. However, despite the strong clinical evidence, few studies have 
examined the effects of exercise training on inflammation-induced behavioral disturbances. 
Furthermore, when exercise, inflammation, and behavior are studied in conjunction in an animal 
model, the majority of literature has used unpredictable chronic mild stress (uCMS) as the 
stimuli for behavioral disturbances rather than a defined inflammatory challenge [81].  uCMS 
utilizes daily unpredictable stress that typically lasts for 3-6 weeks. For example, one day the 
mice may be confronted with a flooded cage for an hour, while the next day the mice must 
tolerate a strobe light for an hour. This experimental paradigm has been shown to increase brain 
proinflammatory cytokine gene expression and induce depressive-like behavior and cognitive 
impairments in mice and rats [82], but the relationship between the induction of the 
proinflammatory response and changes in behaviors has not been well established in this model. 
However, the data indicating the ability of exercise training to reverse stress-associated 
depressive-like behavior are quite strong. Solberg et al. found 6 weeks of voluntary wheel 
running of mice in conjunction with six weeks of uCMS increased sucrose preference and 
decreased FST immobility compared to mice that received uCMS but no prior wheel training 
[83].  These results were similar to Zheng et al., who demonstrated four weeks of wheel training 
in conjunction with uCMS recovered sucrose preference, which was associated with decreased 
hippocampal corticosterone (CORT) expression and increased hippocampal BDNF expression 
[84]. Exactly how BDNF may be mediating depressive-like behavior is unclear, but BDNF may 
be improving the survival of neurons affected by uCMS. Duman et al. proposed an alternative 
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molecular mechanism; these authors discovered four weeks of wheel training increased 
prefrontal cortex insulin-like growth factor 1 (IGF-1), and this increase was associated with a 
protected sucrose preference and FST [85]. While this response appears to be inherently different 
than the BDNF hypothesis, data by Park [86-88] et al. indicate IGF-1 protects brain BDNF 
signaling during an inflammatory challenge [86-88]. Therefore, it is plausible that exercise-
induced IGF-1 could be mediating its anti-depressant effects via BDNF regulation. More 
relevant to our specific aims, a recent study by Liu et al. examined the effects of swim training 
on uCMS induced depressive-like behavior in mice [89].  Following 4 weeks of swim training in 
combination with uCMS, swim trained mice exhibited increased sucrose preference and 
decreased FST immobility compared to uCMS mice that did not swim train. Moreover, these 
behavioral results were associated with reduced prefrontal cortex IFNγ, TNFα, and IDO gene 
expression. To my knowledge, this is the first study to relate exercise-induced attenuation of 
depressive-like behavior with decreased IDO expression/activity . 
To date, only one study has used a defined inflammatory stimulus to examine the effects 
of exercise training on inflammation induced behavioral abnormalities. However, this study 
examined cognitive impairment rather than sickness and depressive-like behavior. Using an 
E.coli infection model, in which the authors had previously shown elevated IL-1β disrupts 
BDNF signaling and cognition, Barrientos et al. elegantly demonstrated six weeks of wheel 
running prevented hippocampal dependent cognitive decline in aged rats [90]. This exercise-
induced protection was related to reduced hippocampal IL-1β protein and elevated BDNF protein 
expression. To further elucidate the mechanisms responsible for the attenuated 
neuroinflammation, isolated primary microglia from the wheel trained and sedentary rats were 
stimulated with a range of LPS doses. As expected, the microglia from the voluntary wheel 
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running (VWR) mice exhibited a significantly reduced sensitivity to LPS, indicating that 
exercise training may ‘reverse’ age-induced microglia priming and the subsequent 
neuroinflammation.  
Together, these data suggest exercise training may attenuate stress/pathogen induced 
neuroinflammation and the accompanying behavioral disturbances. The most logical mechanism 
that has been hypothesized to date is an exercise-mediated protection of BDNF signaling, which 
may protect synaptic plasticity and neuron survival. A caveat to the BDNF hypothesis is that the 
majority of exercise studies only show BDNF protection/upregulation in the hippocampus and 
have not demonstrated a more widespread effect in the brain. Given that depression is a multi-
region brain disorder, employing a global approach to examine the effects of exercise on 
inflammation-induced behavioral disturbances may be more appropriate and realistic. 
Additionally, understanding the differential mechanisms of exercise modality (e.g., voluntary vs. 
forced), duration, intensity, and timing (e.g., prior to vs. after an inflammatory challenge) will 
allow researchers to tailor exercise programs to combat inflammation induced behavioral 
disturbances in humans [91, 92].  
 
2.6 Conclusion 
In conclusion, inflammation is a coordinated nonspecific innate immune response to 
harmful stimuli with the principal goal being elimination of the stimuli and initiation of tissue 
healing. Proinflammatory cytokines produced during inflammation act not only locally at the site 
of infection but also centrally in the brain to induce behavioral changes that promote organism 
recovery and survival from infection. Certain conditions (e.g., aging) sensitize the brain to the 
behavioral effects of cytokines, resulting in prolonged sickness behavior and increased risk of 
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depression. Therapeutic interventions, such as exercise training, may attenuate systemic and 
neural inflammation and may protect against inflammation-induced behavioral abnormalities in 
older individuals.   
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CHAPTER 3 
 
METHODOLOGY 
 
 
The following section is an overview of the methodology used in these studies. The 
information herein was derived from an excellent review by York et al., regarding mouse testing 
methods in Psychoneuroimmunology [93].  For a more detailed description of experimental 
design and methodology, please see the respective manuscripts in Chapters 4, 5, and 6. 
 
3.1 Animals 
 
Aim 1 Animals: Nineteen month-old male C57BL/6 mice were obtained from the National 
Institute of Aging (Bethesda, MD), and singly housed in cages with corn-cob bedding in a 
temperature (23°C) and humidity (45-55%) controlled environment with a 12h dark/light cycle 
(lights off 0900-2100). Mice were allowed ad libitum access to food and water for the entire 
duration of the study and were given 2 weeks to acclimate to the housing conditions prior to 
study commencement. Mice that appeared moribund or lost significant body weight (>20%) 
during the experiments were excluded. All experiments were conducted under the guidelines of 
the University of Illinois, Urbana-Champaign Animal Care and Use Committee. 
 
Aim 2 Animals:  
Experiment 1, Young Adult Mice: Four month-old male C57BL/6 mice were obtained from 
Jackson Laboratory (Bar Harbor, ME), and singly housed in cages with corn-cob bedding in a 
temperature (23°C) and humidity (45-55%) controlled environment with a 12h dark/light cycle 
(lights off 0900-2100). Mice were allowed ad libitum access to food and water for the entire 
duration of the study and were given 2 weeks to acclimate to the housing conditions prior to 
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study commencement. All experiments were conducted under the guidelines of the University of 
Illinois, Urbana-Champaign Animal Care and Use Committee. 
Experiment 2, Aged Mice: Nineteen month-old male C57BL/6 mice were obtained from the 
National Institute of Aging (Bethesda, MD), and singly housed in cages with corn-cob bedding 
in a temperature (23°C) and humidity (45-55%) controlled environment with a 12h dark/light 
cycle (lights off 0900-2100). Mice were allowed ad libitum access to food and water for the 
entire duration of the study and were given 2 weeks to acclimate to the housing conditions prior 
to study commencement. Mice that appeared moribund or lost significant body weight (>20%) 
during the experiments were excluded. All experiments were conducted under the guidelines of 
the University of Illinois, Urbana-Champaign Animal Care and Use Committee. 
 
Aim 3 Animals: Three month-old male balb/c mice were obtained from the Jackson Laboratory 
(Bar Harbor, ME), and singly housed in cages with corn-cob bedding in a temperature (23°C) 
and humidity (45-55%) controlled environment with a 12h dark/light cycle (lights off 0900-
2100). Mice were allowed ad libitum access to food and water for the entire duration of the study 
and were given 2 weeks to acclimate to the housing conditions prior to study commencement. 
All experiments were conducted under the guidelines of the University of Illinois, Urbana-
Champaign Animal Care and Use Committee. 
 
3.2 Exercise Training Methodology 
 
Voluntary Wheel Running (VWR) Aim 1: Due to the voluntary nature of wheel running, 
VWR exerts stronger neuroprotective effects compared to forced treadmill running. For this 
reason, it was chosen as our primary exercise training modality.  Mice were randomized to a 
voluntary wheel running (VWR), locked wheel (Locked), or ‘normal’ (Standard) housing 
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condition for a duration of ten weeks. This duration of training is sufficient to induce metabolic 
adaptations in aged mice. The purpose of using a Locked group is to discern between cage 
enrichment and wheel running effects. VWR mice were individually housed in a plexiglas cage 
(48 L  26 W  15 H cm) that contained a wireless low-profile running wheel (circumference 
37.82 cm)(Med Associates, St. Albans, Vermont). Wheel revolutions were wirelessly relayed via 
telemetry to a computer in the facility. Locked mice were housed in cages identical to VWR 
mice, except their wheels were locked in place; this provided cage enrichment (i.e. novel object), 
but did not allow for exercise training.  Standard mice were housed in smaller cages (30 L  19 
W  12 H cm) without any type of environmental enrichment. 
Voluntary Wheel Running (VWR) Aim 2: Due to the voluntary nature of wheel running, 
VWR exerts stronger neuroprotective effects compared to forced treadmill running. For this 
reason, it was chosen as our primary exercise training modality.  Because we found no 
differences between Locked and Standard mice in Aim 1, we only utilized VWR and Standard 
housing conditions in Aim 2.  Mice were randomized to a voluntary wheel running (VWR) or 
‘normal’ (Standard) housing condition for a duration of 30d (Young Adult Mice) and 70d (Aged 
Mice). This duration of training is sufficient to induce metabolic adaptations for the respective 
age cohorts (unpublished data and [94]. VWR mice were individually housed in a plexiglass 
cage (48 L  26 W  15 H cm) that contained a wireless low-profile running wheel 
(circumference 37.82 cm)(Med Associates, St. Albans, Vermont). Wheel revolutions were 
wirelessly relayed via telemetry to a computer in the facility. Standard mice were housed in 
smaller cages (30 L  19 W  12 H cm) without any type of environmental enrichment. 
Voluntary Wheel Running (VWR) Aim 3: For Aim 3, we decided to use VWR as a dependent 
variable rather than an independent variable. That is, VWR was used as a measure of sickness 
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instead of a training modality. All mice in Aim 3 were individually housed in a plexiglass cage 
(48 L  26 W  15 H cm) that contained a wireless low-profile running wheel (circumference 
37.82 cm)(Med Associates, St. Albans, Vermont). Wheel revolutions were wirelessly relayed via 
telemetry to a computer in the facility. Standard mice were housed in smaller cages (30 L  19 
W  12 H cm) without any type of environmental enrichment. 
Treadmill Exercise Training Aim 3: In Aim three we wanted to examine the effects of forced 
treadmill exercise after BCG inoculation on sickness and depressive-like behavior.  Beginning at 
4h post-inoculation, mice were treadmill run once per day for thirty minutes at an intensity of 8-
12m/m (60-70% VO2max) until the end of the study; a control group of mice had their food 
removed and was exposed to the noise of the treadmill for the same duration as the treadmill 
runners. 
Treadmill Test of Fatigability Aims 1 and 2:  Forced treadmill running measures mouse 
training adaptations compared to wheel running. To assess VWR induced training adaptations in 
Aims 1 and 2, we measured forced exercise fatigability at the conclusion of the training period, 
72h prior to LPS injection. Mice ran until exhaustion on a motor-driven treadmill at gradually 
increasing speeds from 6-21m/min. Exhaustion was defined as the point at which the mouse 
refused to run despite prompting by mild prodding with the hand for a period of 10 s; electric 
shock was not used in this test. 
 
3.3 Lipopolysaccharide (LPS) and Bacillus Calmette–Guérin (BCG) Administration 
LPS: LPS is a component of the Gram negative bacterial cell wall, and is commonly used to 
stimulate the innate immune system in a similar manner to bacterial infection. However, unlike 
bacteria which continue replicating and stimulating the immune system, LPS is short lived and 
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non-replicating, and thus an excellent and widely used model to assess cytokine-induced 
sickness behavior and depressive-like behavior.  LPS interacts in a complex fashion with toll-like 
receptor (TLR)-4 on host immune cells including macrophages where it signals through nuclear 
factor kappa beta (NF- B) to induce pro-inflammatory gene expression (Beutler 2003). 
LPS Administration Aim 1: After training intervention, all mice were removed from their 
respective housing conditions cage and singly housed in clean cages (30 L  19 W  12 H cm) 
for a 24h period prior to treatment in order to washout any acute effects of the last wheel training 
session as acute exercise has been shown to affect LPS responses (Starkie et al., 2003; Tanaka et 
al., 2010). This was necessary to be able to separate exercise training effects versus influences 
due to the last exercise session. Following this 24h period, mice were randomized and injected 
intraperitoneally (i.p.) with saline or Escherichia coli LPS (lot 3129, serotype 0127:B8, Sigma) 
at one of four different doses (0.02 mg/kg, 0.08 mg/kg, 0.16 mg/kg, 0.33 mg/kg). Injection 
occurred at the onset of the dark cycle. The purpose of the different LPS doses was to ascertain 
whether potential exercise-induced effects occurred in a dose-dependent manner. This range of 
LPS doses was selected based upon previous studies demonstrating that 0.33mg/kg LPS 
produced prolonged sickness behavior in aged, compared to young mice [2], and 0.02mg/kg 
being the lowest dose capable of inducing statistically significant changes in sickness behaviors 
when compared to saline treated mice.  
LPS Administration Aim 2. Given that aged mice exhibit a greater sensitivity to LPS-induced 
neuroinflammation and behavioral disturbances, we used different LPS doses for Experiment 1 
and Experiment 2. Both doses, however, represent the minimum effective dose capable of 
inducing depressive-like behavior in the respective age cohorts of C57bl/6 mice, as determined 
by thorough titration experiments (unpublished data).  
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Experiment 1, Young Adult Mice: After 30d of VWR training, mice were randomized and 
injected intraperitoneally (i.p.) with saline or Escherichia coli LPS (lot 3129, serotype 0127:B8, 
Sigma) at a dose of 0.83 mg/kg.    
Experiment 2, Aged Mice: Following 70d of VWR training, aged mice were randomized and 
injected intraperitoneally (i.p.) with saline or Escherichia coli LPS (lot 3129, serotype 0127:B8, 
Sigma) at a dose of 0.33 mg/kg.    
 
BCG: Infection of mice with BCG is a well validated model of chronic immune activation. Mice 
chronically infected with BCG display an acute episode of sickness behavior (0-6d), followed by 
depressive-like behaviors (7-14d). These behavioral abnormalities are similar to symptoms 
typically observed in patients undergoing immunotherapy [37, 42]. For this reason, infection of 
mice with BCG represents a suitable model to study the depressive-like behavioral implications 
of chronic inflammation. BCG also chronically induces both IDO and proinflammatory 
cytokines such as IFNγ and TNFα [37, 42]. The advantages of BCG compared LPS are that BCG 
allows for the temporal dissociation between sickness behavior and depressive-like behavior.  
BCG Administration Aim 3: In Aim 3, mice were inoculated with either saline or 10
8
 CFU 
BCG (Organon-Tice; Lot 4511103) via i.p. injection.  Injection occurred at the onset of the dark 
cycle. This dose was based on previous studies from our lab and O’Connor et al. demonstrating it 
to be the minimum effective dose to induce prolonged (>6d) depressive like behavior in young 
mice [37]. 
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3.4 Assessment of Sickness Behavior 
 Proinflammatory cytokines propagate signals to various brain structures, including the 
hypothalamus, hippocampus, amygdala, and prefrontal cortex, to invoke a constellation of 
motivated behavioral adaptations (i.e., ‘sickness behavior’). These adaptations allocate energy 
and resources towards the immune response and support recovery from infection [15]. Sickness 
behaviors include loss of appetite and body weight, fatigue, withdrawal from normal social 
activities, altered cognition, hyperalgesia, and fever [19, 33]All assessments of sickness behavior 
occurred during the dark cycle at the same time each day. For a more detailed description of 
behavioral assessments (e.g. time-points), please see the respective manuscripts in Chapters 4, 5, 
and 6. 
 
Body Mass: While body mass loss is not a behavior, per se, it is an extremely sensitive measure 
of sickness. The loss of body mass observed during sickness is attributed to decreased food and 
fluid intake, resulting in dehydration and lean body mass loss.  To assess body mass changes, 
mice were weighed at the same time everyday to reduce variability based on circadian feeding 
patterns. A baseline collection period of >4d should was used to determine a baseline body 
weight; this is necessary in case post hoc normalization of body weight is required. 
Food Intake: Food consumption, or rather, food disappearance, is a useful indicator of sickness, 
as sick animals typically exhibit anorexia.  The term food disappearance is used rather than food 
intake, because some food inadvertently falls in the cage bedding.  To measure food 
disappearance, food should was weighed at the desired intervals (e.g. 24h), and the difference 
between the measured values was calculated as food disappearance.  As with body mass, a 
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baseline collection period of >4d should was used to determine a baseline food intake; this is 
necessary in case post hoc normalization of food intake is required. 
Fluid Intake: Fluid intake, like food intake, is a useful indicator of sickness, as sick animals 
typically exhibit adipsia.  Usually food and fluid intake go “hand in hand” in regard to decrease 
then recovery.  To measure fluid consumption, fluid should was weighed at the desired intervals 
(e.g. 24h), and the difference between the measured values was calculated as fluid 
disappearance.  A baseline collection period of >4d should was used to determine a baseline fluid 
intake; this is necessary in case post hoc normalization of fluid intake is required. 
Locomotor activity (LMA): As lethargy is a primary symptom of sickness behavior, LMA can 
be used as an easy and high-throughput measure of sickness behavior.  LMA is ideally conducted 
in a novel environment, as the motivation to explore is stronger in this situation in healthy 
animals compared to sick animals. For this test, mice were individually placed into a clean, novel 
cage (30 L  19 W  12 H cm) devoid of bedding or litter, and LMA was video-recorded for a 5-
minute period.  Videos were analyzed by dividing the cage into four virtual quadrants and 
counting the number of quadrant entrances over the 5-minute period; counting was done by a 
trained observer who was blind to experimental treatments. 
 
3.5 Assessment of Depressive-Like Behavior 
 The underlying cause of depression is unknown, making it difficult to recreate the disease 
in an animal model [95].  Current models attempt to produce quantifiable measures of human 
symptoms (e.g. Anhedonia) in animals [95].  Furthermore, a majority of human depression 
symptoms are subjective, which cannot be assessed in animals[95] .  Animal models of 
depression are evaluated based on their reliability, their ability to accurately predict human 
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outcomes (predictive validity), their ability to reproduce in animals aspects of illness in humans 
(face validity), and the extent to which them model depression etiology in humans (construct 
validity) [95].  The experimental design utilized in our experiments adequately satisfies these 
criteria. Inflammation-induced depression is a real occurrence in humans, and we use LPS to 
model this in mice (LPS = construct validity).  Anhedonia is a real symptom of human 
depression, and we use sucrose preference testing to model this in mice (sucrose preference = 
face validity).  Lastly, the tail suspension test is a classic model of predicting the efficacy of anti-
depressant drugs in humans (tail suspension = predictive validity).  When using depressive-like 
behavior that involves movement (e.g. TST), any sickness-induced reduced locomotion 
confounds the assessment of depressive-like behavior. Therefore, depressive-like behavior 
testing should be performed after overt sickness behaviors have subsided and locomotion has 
returned to normal. These tests are validated as measures of ‘depressive-like behavior’ because 
pretreatment with anti-depressants reduces the respective depressive-like behavior outcome (e.g. 
immobility). For a more detailed description of behavioral assessments (e.g. time-points), please 
see the respective manuscripts. 
 
Tail Suspension Test (TST): The tail suspension test (TST), a standardized test of depressive-
like behavior in which depression is inferred from increased duration of immobility, was 
conducted as previously described by O’Connor et al [43]. Briefly, mice were taken from their 
home cage and hung from their tail on a hook connected to a strain gauge for a period of 6 
minutes. A computerized system for processing the force exerted on the gauge (Mouse Tail 
Suspension Package, MED-TSS-MS; Med Associates, St Albans, VT, USA) collected and 
analyzed the movements of each individual mouse. An immobility threshold was determined by 
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establishing an activity level that would exclude all movements and only encompass immobility. 
Time below this threshold indicated the time of immobility. 
 
Sucrose Preference Test (SPT).  Anhedonia is a key component of depression, and can be 
measured in mice by their preference to consume a sweetened solution. A sucrose preference test 
was performed following a three-day training program, during the 24 h period following LPS 
administration. Mice were presented with two identical volumetric drinking tubes containing 
either water or a 1% sucrose solution. Bottles were weighed to before and after the 24h period to 
measure fluid consumption of each respective solution. Bottle position (right v. left) was 
alternated each training period to reduce potential bias from place preference. Sucrose preference 
was calculated using the following formula: [Sucrose intake / (water intake + sucrose 
intake)] × 100. 
 
3.6 Tissue Cytokine Quantification 
Quantitative Reverse Transcriptions Polymerase Chain Reaction (qRT-PCR): qRT-PCR is 
a commonly used technique in molecular biology to detect RNA expression levels. Briefly, a 
RNA template is first converted into a complementary DNA (cDNA) using a reverse 
transcriptase. Following that, the cDNA is then used as a template for exponential amplification 
using PCR. For our study, quantitative real-time reverse transcription PCR was performed on an 
Applied Biosystems Prism 7900 using TaqMan gene expression assays for TNF-  
(Mm0043258_m1), IL-1  (Mm00434228_m1), IL-6 (Mm00446190_m1), IL-10 
(Mm00439616_m1), BDNF (Mm01334042_m1), IDO (Mm00492586_m)  and glyceraldehyde 
3-phosphate dehydrogenase (Mm999999_g1) purchased from Applied Biosystems (Foster City, 
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CA).  Reactions were performed in duplicate according to the manufacturer’s instructions. 
Relative quantitative measurement of target gene expression was conducted using the Ct 
method with glyceraldehyde 3-phosphate as the endogenous house-keeping gene and VWR 
saline treated mice were used as the referent group. We chose to analyze TNF- , IL-1 , IL-6, IL-
10, and IDO because they are critical mediators of inflammation-induced sickness and 
depressive-like behavior and are affected by aging [2, 96, 97]. BDNF is a critical neurogenic 
growth factor that is highly influenced by exercise (Zoladz et al. 2010). Our group has shown 
that inflammatory stimuli such as LPS can reduce brain BDNF (Park et al 2011).  
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CHAPTER 4 
THE EFFECTS OF VOLUNTARY WHEEL RUNNING ON LPS-INDUCED SICKNESS 
BEHAVIOR IN AGED MICE
2
 
 
4.1 Abstract 
Peripheral stimulation of the innate immune system with LPS causes exaggerated 
neuroinflammation and prolonged sickness behavior in aged mice.  Regular moderate intensity 
exercise has been shown to exert anti-inflammatory effects that may protect against inappropriate 
neuroinflammation and sickness in aged mice. The purpose of this study was to test the 
hypothesis that voluntary wheel running would attenuate LPS-induced sickness behavior and 
proinflammatory cytokine gene expression in ~22-month-old C57BL/6J mice.  Mice were 
housed with a running wheel (VWR), locked-wheel (Locked), or no wheel (Standard) for 10 
weeks, after which they were intraperitoneally injected with LPS across a range of doses (0.02, 
0.08, 0.16, 0.33 mg/kg). VWR mice ran on average 3.5 km/day and lost significantly more body 
weight and body fat, and increased their forced exercise tolerance compared to Locked and 
Shoebox mice. VWR had no effect on LPS-induced anorexia, adipsia, weight-loss, or reductions 
in locomotor activity at any LPS dose when compared to Locked and Shoebox groups. LPS 
induced sickness behavior in a dose-dependent fashion (0.33>0.02 mg/kg). Twenty-four hours 
post-injection (0.33mg/kg LPS or Saline) we found a LPS-induced upregulation of whole brain 
TNFα, IL-1β, -10 mRNA, and increased IL-1β -6 in the spleen and liver; these 
effects were not attenuated by VWR. We conclude that VWR does not reduce LPS-induced 
                                                        
2 Reprinted from Brain, Behavior, and Immunity, 29, S.A. Martin, B. A. Pence, R. Greene, S. 
Johnson, R. Dantzer, K.W. Kelley, J.A. Woods, Effects of Voluntary Wheel Running on LPS-
induced Sickness Behavior in Aged Mice, 113-123, 2013, with permission from Elsevier. 
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exaggerated or prolonged sickness behavior in aged animals, or 24h post-injection (0.33mg/kg 
LPS or Saline) brain and peripheral proinflammatory cytokine gene expression. The necessity of 
the sickness response is critical for survival and may outweigh the subtle benefits of exercise 
training in aged animals.   
 
4.2 Introduction  
 
Peripheral infection stimulates the innate immune system to produce pro-inflammatory 
cytokines, such as tumor necrosis factor (TNF)-α, interleukin(IL)-1β, and IL-6, which signal 
through various communication pathways to induce a ‘mirror image’ of cytokine expression 
within the brain [19, 33, 96]. Centrally, these pro-inflammatory cytokines act directly or 
indirectly on neurons and supporting cells (e.g. microglia, astrocytes) to alter autonomic nervous 
and endocrine system output to regulate the body’s response to infection. IL-1β, for example, 
induces activation of the hypothalamic-pituitary-adrenal axis and the production of 
corticosteroids which attenuate the pro-inflammatory response in a negative feedback loop [32].  
Moreover, these cytokines invoke a constellation of motivated behavioral adaptations (e.g. 
‘sickness behavior’), which allocate energy and resources towards the immune response, and 
support recovery from infection. Sickness behaviors include: loss of appetite and body weight, 
fatigue, withdrawal from normal social activities, altered cognition, hyperalgesia, and fever [19, 
33]. The importance of such behaviors is bolstered by the powerful observation that forced tube 
feeding of anorexic sick mice to normal ad libitum levels results in greater mortality to Listeria 
monocytogenes [34]. 
Anybody who has been ill has experienced sickness behavior, which, depending on the 
pathogen, infectious load, and host factors, can either be mild or severely debilitating. 
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Fortunately for most, these symptoms are transient. One host factor affecting sickness behavior 
is aging. Normal aging is accompanied by changes in immune function that can result in greater 
infectious disease susceptibility in humans [98] and animals [99]. Older subjects exhibit 
exaggerated behavioral and cognitive deficits following immune activation [2, 100-102]. 
Important for the current study, 24 hr following peripheral lipopolysaccharide (LPS, 0.33 mg/kg) 
administration, aged mice exhibited significantly decreased social behavior, locomotor activity, 
food intake, and body weight whereas young mice are fully recovered at that time [2]. LPS is a 
component of the Gram negative bacterial cell wall, and is commonly used to stimulate the 
innate immune system in a similar manner to bacterial infection. However, unlike bacteria which 
continue replicating and stimulating the immune system, LPS is short lived and non-replicating, 
and thus an excellent and widely used model to assess cytokine-induced sickness behavior.  LPS 
interacts in a complex fashion with toll-like receptor (TLR)-4 on host immune cells including 
macrophages where it signals through nuclear factor kappa beta (NF- B) to induce pro-
inflammatory gene expression.  The protracted behavioral effects associated with aging can be 
attributed, in part, to exaggerated and less resilient inflammatory responses in the periphery and 
within the central nervous system, as aged animals show higher pro-inflammatory cytokines 
levels in the brain in response to peripheral immune activation [2, 97, 101]. The biological basis 
of this aging phenomenon is not entirely understood, but putative mechanisms indicate an age-
related dysregulation of peripheral inflammation, priming of microglia cells, and dysregulated 
neuron/microglia interaction [66, 97, 103].  
Strategies to prevent or attenuate age-associated exaggerated or prolonged inflammation and 
sickness behavior could assist elderly in recovery from infectious episodes. Our lab has a 
longstanding interest in exploring the ability of regular exercise to alleviate dysregulated 
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inflammation in aging, obesity and infectious challenges [104-107].  Studies examining the 
effects of exercise training on various responses to LPS in younger rodents have produced mixed 
results [108-114]. For example, Criswell et al [110] found 12 weeks of treadmill running led to 
an exaggerated serum TNFα response when compared to sedentary rats. In contrast, Chen et al 
[108] found the exact opposite; 4 weeks of treadmill training attenuated the serum TNFα 
response to LPS. No studies have examined whether exercise training can affect exaggerated 
central and peripheral inflammation induced by LPS in aged animals, and whether this translates 
to attenuated inflammation-induced sickness behavior in aged animals.  
Therefore, using a paradigm (LPS-induced sickness behavior) that has previously been 
shown to be sensitive to endogenous and exogenous factors [2, 115], we sought to examine the 
influence of 10 weeks of voluntary wheel running (VWR) on LPS-induced sickness behaviors 
and whether changes in these behaviors were accompanied by changes in central and peripheral 
proinflammatory cytokine gene expression in aged mice. We purposefully did not include young 
mice in these experiments because the aging effect has been well documented [2, 100] and our 
primary interest was whether exercise training impacts age-associated protracted sickness 
behaviors.  We hypothesized voluntary wheel running would induce anti-inflammatory effects 
and attenuate LPS-induced sickness behaviors in aged mice. 
 
4.3 Materials and Methods 
Animals. Nineteen month-old male C57BL/6 mice were obtained from the National Institute of 
Aging (Bethesda, MD), and singly housed in cages with corn-cob bedding in a temperature 
(23°C) and humidity (45-55%) controlled environment with a 12h dark/light cycle (lights off 
0900-2100). Mice were allowed ad libitum access to food and water for the entire duration of the 
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study and were given 2 weeks to acclimate to the housing conditions prior to study 
commencement. Mice that appeared moribund or lost significant body weight (>20%) during the 
experiments were excluded. All experiments were conducted under the guidelines of the 
University of Illinois, Urbana-Champaign Animal Care and Use Committee. 
 
Voluntary Wheel Training. Following acclimation, mice were randomized to a voluntary wheel 
running (VWR), locked wheel (Locked), or ‘normal’ (Standard) housing condition for a duration 
of 10 weeks. The VWR mice were individually housed in a plexiglass cage (48 L  26 W  15 H 
cm) that contained a wireless low-profile running wheel (circumference 37.82 cm)(Med 
Associates, St. Albans, Vermont). Wheel revolutions were wirelessly relayed via telemetry to a 
computer in the facility. To discern between cage enrichment and wheel running effects, we used 
two different control groups. Locked mice were housed in cages identical to VWR mice, except 
their wheels were locked in place; this provided cage enrichment (i.e. novel object), but did not 
allow for exercise training.  Standard mice were housed in smaller cages (30 L  19 W  12 H 
cm) without any type of environmental enrichment. 
 
LPS administration. After ten weeks of training, all mice were removed from their respective 
housing conditions cage and singly housed in clean cages (30 L  19 W  12 H cm) for a 24h 
period prior to treatment in order to washout any acute effects of the last wheel training session 
as acute exercise has been shown to affect LPS responses (Starkie et al., 2003; Tanaka et al., 
2010). This was necessary to be able to separate exercise training effects versus influences due to 
the last exercise session. Following this 24h period, mice were randomized and injected 
intraperitoneally (i.p.) with saline or Escherichia coli LPS (lot 3129, serotype 0127:B8, Sigma) 
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at one of four different doses (0.02 mg/kg, 0.08 mg/kg, 0.16 mg/kg, 0.33 mg/kg).  The purpose 
of the different LPS doses was to ascertain whether potential exercise-induced effects occurred 
in a dose-dependent manner. This range of LPS doses was selected based upon previous studies 
demonstrating that 0.33mg/kg LPS produced prolonged sickness behavior in aged, compared to 
young mice [2], and 0.02mg/kg being the lowest dose capable of inducing statistically significant 
changes in sickness behaviors when compared to saline treated mice.  
 
Treadmill Running Test. To assess VWR induced training adaptations, we measured forced 
exercise fatigability in a cohort of saline-injected mice, 96h post-injection. Mice ran until 
exhaustion on a motor-driven treadmill at gradually increasing speeds from 6-21m/min. 
Exhaustion was defined as the point at which the mouse refused to run despite prompting by 
mild prodding with the hand for a period of 10 s; electric shock was not used in this test.  
 
 Measurement of sickness behavior. Sickness behavior was assessed by changes in body 
weight, food and fluid intake, and locomotor activity (LMA). Body weight was measured daily 
for eight days post-injection, while food and fluid intake were measured for seven and four days, 
respectively. Decreased LMA in a novel environment is a sensitive measure of sickness behavior 
[96]. For this test, mice were individually placed into a clean, novel cage (30 L  19 W  12 H 
cm) devoid of bedding or litter, and LMA was video-recorded for a 5-minute period.  Videos 
were analyzed by dividing the cage into four virtual quadrants and counting the number of 
quadrant entrances over the 5-minute period; counting was done by a trained observer who was 
blind to experimental treatments. 
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Study design. In the first experiment, body weight, food and fluid intake, and LMA were 
measured at numerous time-points after injection of saline or one of 4 different LPS doses.  In a 
separate but identical experiment, mice were killed by CO2 exposure at 24 h post-Saline or 0.33 
mg/kg LPS injection for tissue collection to coincide with sickness behavior data collected in the 
first experiment. This time-point and LPS dosage were chosen based upon previous research 
demonstrating clear age-related differences in the sickness and inflammatory response to i.p. 
LPS [2].  Separate mice were used for behavioral and tissue experiments because behavioral 
manipulation may confound sensitive measures of tissue gene expression. Tissues were dissected 
out after transcardial perfusion with ice-cold PBS saline. 
 
RNA extraction and reverse transcription. Total RNA from whole brain, epididymal adipose, 
spleen, and liver was extracted with Qiagen RNeasy Mini Kits (Valencia, CA).  We chose these 
tissues because they demonstrate age-associated exaggerated inflammation following LPS 
challenge [2, 103, 116]. Reverse transcription reactions were completed in an Eppendorf 
Mastercycler Thermocycler (Hamburg, Germany) using an Applied Biosystem (Foster City, CA) 
High Capacity reverse transcriptase kit with 2,000 ng total RNA and random primers for each 
reaction.   
 
Real-Time RT-PCR. Quantitative real-time reverse transcription PCR was performed on an 
Applied Biosystems Prism 7900 using TaqMan gene expression assays for TNF-  
(Mm0043258_m1), IL-1  (Mm00434228_m1), IL-6 (Mm00446190_m1), IL-10 
(Mm00439616_m1), BDNF (Mm01334042_m1),  and glyceraldehyde 3-phosphate 
dehydrogenase (Mm999999_g1) purchased from Applied Biosystems (Foster City, CA).  
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Reactions were performed in duplicate according to the manufacturer’s instructions. Relative 
quantitative measurement of target gene expression was conducted using the Ct method with 
glyceraldehyde 3-phosphate as the endogenous house-keeping gene and VWR saline treated 
mice were used as the referent group. We chose to analyze TNF- , IL-1 , IL-6, and IL-10 
because they are critical mediators of inflammation-induced sickness behavior and are affected 
by aging [2, 96, 97]. BDNF is a critical neurogenic growth factor that is highly influenced by 
exercise (Zoladz et al. 2010). Our group has shown that inflammatory stimuli such as LPS can 
reduce brain BDNF (Park et al 2011). 
 
Statistical Analysis. Data were analyzed using SPSS v18 (Chicago, IL). All data were tested for 
normality using the Shapiro-Wilk test. Data not approximating a normal distribution were 
logarithmically transformed before parametric statistical analysis. In these instances, we report 
the non-transformed data in the figures for clarity with F and p values from statistical analysis 
run on transformed data. Mortality data were analyzed using a Mantel-Cox log-rank test.  
Intervention induced differences in body weight and fatigability were detected using one-way 
analysis of variance (ANOVA)(intervention = VWR, Locked, Standard). Intervention induced 
differences in gene expression were detected using a 3 (VWR, Locked, Standard) x 2 (Saline 
0.33 mg/kg LPS) ANOVA.  Because our primary objective was to assess exercise induced 
changes in sickness behavior, we analyzed data at each LPS dosage.  We did, however, analyze 
LPS doses independent of intervention to ensure the selected LPS doses affected sickness 
behavior in a dose-dependent manner.  LPS-induced changes in food and fluid intake, body 
weight and LMA were analyzed using a similar 3 (housing condition) x 2 (LPS, Saline) ANOVA 
with repeated measures. When appropriate, differences between treatments at each time point 
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were determined using the Fisher’s least significant difference post-hoc multiple pairwise 
comparisons. Data are expressed as mean  SEM. The alpha level was set at p < 0.05 and all 
tests were two-tailed. 
 
4.4 Results 
Effects of VWR on LPS-induced mortality, body weight, and fatigability in aged mice. 
There were no statistically significant pre-intervention differences in body weights between 
housing conditions (F2,203=1.42; p=0.239) (Table 1). VWR mice ran an average of 3.54 km per 
day (Table 1). There were no statistically significant differences in daily running distance 
between any of the wheel running groups across LPS dose experiments (F4,61=1.158; p=0.339). 
VWR mice lost significantly more body weight and epididymal fat compared to Locked and 
Standard mice (Table 1). Interestingly, mice housed with a Locked wheel lost significantly more 
body weight (but not epididymal fat) when compared to Standard housed mice (F2,203=3.58; 
p=0.00) (Table 1). To assess VWR-induced improvements in muscle endurance, we subjected 
cohorts (n = 8-12) of mice from each intervention to a forced treadmill exercise test to 
exhaustion. VWR mice ran the longest before reaching exhaustion, more than doubling the 
length of time run compared to the Locked and Standard groups (F2,29=37.18; p=0.00) (Table 1).  
Mortality was observed at all LPS doses in these old mice (Table 2) and there were no 
differences between VWR, Locked, and Standard groups for any of the LPS doses (χ2 = 3.80; p = 
0.15, χ2 = 0.18; p = 0.94, χ2 = 2.21; p = 0.33, and χ2 = 2.63; p = 0.27, for the 0.02, 0.08, 0.16 and 
0.33 mg/kg doses, respectively) (Table 2). We did not have enough mice to asses potential 
intervention-induced differences in mortality, but when comparing mortality across LPS doses, 
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there was no statistically significant LPS dose-effect, indicating that aged mice are extremely 
sensitive to LPS independent of LPS dose (χ2 = 4.532; p = 0.21) (Table 2).  
 
Effects of VWR LPS-induced Sickness Indicators 
Food intake. For clarity, we present all saline treated groups in Figure 4a as there were 
no statistically significant differences between them. As expected, 0.33 mg/kg LPS resulted in a 
significant reduction in food intake compared to saline injected mice at 24h and 48h post-
injection (Figure 4b), but there were no statistically significant differences between groups (time 
x intervention x treatment interaction: F14, 700 =1.04; p=0.41).   At the 0.02, 0.08, and 0.16 mg/kg 
LPS doses, we observed a significant reduction in food intake 24h-post injection, but similar to 
the 0.33 mg/kg LPS dose, there were no statistically significant differences between groups (time 
x intervention x treatment interactions: F14, 693 =0.94, p=0.51; F14, 672 =0.74, p=0.74; F14, 707 =0.72, 
p=0.76 for the 0.02, 0.08 and 0.16 mg/kg doses, respectively) (Figure 1c-e).  Comparison across 
LPS doses revealed statistically significant differences in LPS-induced anorexia, with the 0.02 
mg/kg dose reducing food intake to a lesser extent at 24h and 48h compared to all other LPS 
doses, and the 0.33 mg/kg dose reducing food intake to a greater extent than all other LPS doses 
at 24h, 48h, and 96h. Food intake returned to baseline levels at 48, 48, 72, 96h for the 0.02, 0.08, 
0.16, and 0.33 mg/kg doses, respectively. At the 3 lower doses of LPS, we observed a 
hyperphagic response once food intake returned to baseline levels (Figures 4c-e). 
Fluid intake. For clarity, we present all saline treated groups in Figure 5a as there were 
no statistically significant differences between them. Like LPS-induced anorexia, all LPS doses 
significantly reduced fluid intake 24h post-LPS injection, but there were no intervention induced 
differences between 3 of the doses (time x intervention x treatment interactions: F8, 396 =0.78, 
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p=0.62; F8, 384 =1.84, p=0.068; F8, 408 =0.29, p=0.97 for the 0.02, 0.08 and 0.33 mg/kg doses, 
respectively) (Figure 5b-e). We did find a 3-way interaction at the 0.16 mg/kg dose (F8, 404 
=2.11, p=0.033), but post-hoc analysis revealed that the interaction was not a function of 
intervention-induced differences in LPS response, but rather fluid intake differences between 
saline injected groups. More specifically, VWR saline-treated mice demonstrated significantly 
higher fluid intake at 24h and 48h post-injection, compared to Locked and Standard saline-
treated mice. Comparison across LPS doses revealed statistically significant differences in LPS-
induced adipsia at 24 and 48h post-injection, with 0.02 mg/kg reducing fluid intake to a lesser 
extent compared to all other LPS doses at 24h and compared to 0.16 and 0.33 mg/kg doses at 
48h. The 0.33 mg/kg dose reduced fluid intake to a greater extent than all other LPS doses at 
24h; there were no statistically significant fluid intake differences between the 0.16 and 0.08 
mg/kg doses.  By 48h, fluid intake had recovered near baseline, and there were no significant 
differences between LPS doses. 
Body weight loss. For clarity, we present all saline treated groups in Figure 6a separately 
from LPS-treated groups. Interestingly, we found that the VWR saline-treated mice had higher 
body weight when compared to locked and standard housed mice (Figure 6a). We believe this to 
be because the VWR mice were removed from their wheels thus reducing their daily energy 
expenditure. All LPS injected mice lost statistically significant amounts of body weight post-LPS 
(Figure 6b-e). There were no significant differences between groups at the 0.02 and 0.33 mg/kg 
doses (time x intervention x treatment interactions: F16, 792 =0.56, p=0.91; F16, 800 =1.38, p=0.15 
for 0.02, 0.33 mg/kg, respectively) (Figure 6b,e).  We did find significant 3-way interactions at 
the 0.08 and 0.16 mg/kg doses (F16, 768 =2.14; p=0.006 and F16, 808 =2.12; p=0.006 for 0.08 and 
0.16 mg/kg, respectively)(Figure 6c,d). Similar to fluid intake, these interactions were not a 
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function of intervention-induced differences in LPS response, but rather body weight differences 
between saline injected groups (Figure 6a).  Comparison across LPS dose revealed a significant 
effect, where 0.02 mg/kg LPS reduced body weight to a lesser extent at 8, 24, 48, 72, and 96h 
compared to all other LPS doses. There were no statistically significant body weight loss 
differences between all other doses.  
Locomotor activity. For clarity, we present all saline treated groups in Figure 7a as there 
were no statistically significant differences between them. We assessed LMA at 8, 24, 48, and 
72h post-injection, and as expected we observed a significant LPS-induced decrease in LMA. 
However, there were no significant effects of housing condition (time x intervention x treatment 
interactions: F6, 294 =0.31, p=0.93: F6, 285 =0.33, p=0.92; F6, 300 =0.84, p=0.54; F6, 297 =0.77, p=0.60 
for 0.02, 0.08, 0.16 and 0.33 mg/kg, respectively) (Figure 7b-e). Comparison across LPS doses 
indicated that at 8, 24, 48, and 72h post-injection, the 0.02 mg/kg dose induced the smallest 
reduction in LMA compared to the higher three doses, which were not statistically different from 
each other at any time-point.  
 
Effects of VWR on LPS-induced brain gene expression 24 hr post-LPS.   
To corroborate our behavioral data, we investigated whether VWR could mitigate LPS-induced 
(e.g. 0.33mg/kg) gene expression changes in the brain. LPS administration resulted in a 
significant increase in brain TNF-  (treatment F1,56 = 55.5; p < 0.001), IL-1  (treatment F1,56 = 
54.4; p < 0.001), and IL-10 (treatment F1,56 = 23.87; p < 0.001), but not IL-6 (treatment F1,56 = 
2.22; p = 0.14) mRNA in all groups (Figure 8). VWR, as applied in this study, could not 
attenuate the reduction in brain BDNF mRNA expression (intervention x treatment F2,56 = 0.23; p 
= 0.79) (Figure 8). There were no intervention main effects or intervention by treatment 
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interactions (p’s for interactions = 0.43, 0.77, 0.95, 0.98, 0.79 for TNF-α, IL-1β, IL-6, IL-10 and 
BDNF, respectively) indicating that VWR had no effect on expression of these genes within the 
brain 24 hr post-LPS. These data support our findings of a lack of effect of VWR on sickness 
behavior induced by LPS. 
 
Effects of VWR on LPS-induced peripheral pro-inflammatory cytokine gene expression.   
As peripheral inflammation induces brain inflammation (Dantzer, 2001), we sought to determine 
if VWR attenuated LPS-induced inflammatory cytokine expression in peripheral tissues. In the 
spleen (Figure 9a), LPS significantly reduced TNF  (treatment F1,56 = 109; p < 0.001) and 
increased IL-1  (treatment F1,56 = 17; p < 0.001) and IL-6 (treatment F1,56 = 9.5; p < 0.005) 
mRNA in all groups 24hr post-LPS. There were no intervention main effects or intervention by 
treatment interactions (p’s for interactions = 0.09, 0.36, and 0.59 for TNF-α, IL-1β, and IL-6 
respectively). In the liver (Figure 9b), LPS significantly increased TNF-  (treatment F1,56 = 
18.82; p < 0.001), IL-1  (treatment F1,56 = 29.818; p < 0.001), and IL-6 (treatment F1,56 = 8.25; p 
= 0.006)  in all intervention groups 24hr post-LPS. There were no intervention main effects or 
intervention by treatment interactions (p’s for interactions = 0.66, 0.50, and 0.92 for TNF-α, IL-
1β, and IL-6 respectively). These data support our brain gene expression and behavior 
observations. 
 
4.5 Discussion 
 
We investigated whether a voluntary wheel running intervention could attenuate 
exaggerated and prolonged LPS induced sickness behavior in aged mice. Ten weeks of voluntary 
wheel running induced expected training adaptations including weight and fat loss and increased 
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forced exercise performance. VWR, locked wheel, and standard housed mice injected with LPS 
exhibited a significant reduction in food and fluid intake post-injection resulting in weight loss 
that, depending on LPS dose, did not return to baseline until up to 6 days post-injection. In 
addition to the anorexic/adipsic-induced weight loss, LPS also induced a significant reduction in 
locomotor activity. Contrary to our hypothesis, there were no differences in sickness behavior 
responses to LPS between VWR, Locked, and Standard mice. To further support the lack of an 
exercise effect on sickness behavior, we calculated correlations between average daily wheel 
running distance and peak sickness behavior (i.e. 24h body weight, 24h food intake, 24h fluid 
intake, 8h LMA), and as expected they were not significant. These data indicate that exercise 
training does not protect aged mice from exaggerated or prolonged sickness behavior in this 
model.   
An understanding of the evolutionary basis of an appropriate sickness response may help 
reconcile this finding that did not support our a priori hypothesis. Sickness behavior is a critical 
survival mechanism primitive to all organisms and could be too essential of a response to be 
affected by exercise training [96]. Several studies have shown inhibiting certain aspects of the 
sickness response results in decreased survival of infected animals. For example, animals housed 
in a cold environment or treated with an antipyretic drug display higher mortality rates following 
infection, suggesting an adequate febrile response is critical for host defense and survival [117].  
Additionally, mice gavage-fed to levels of non-infected mice following bacterial infection 
exhibit reduced survival, indicating the importance of anorexia in the sickness response [34]. The 
highly coordinated responses of sickness behavior are crucial to organism survival. However, it 
is unclear whether exaggerated and/or prolonged sickness behavior is detrimental or beneficial 
for the survival of aged organisms. It could be hypothesized that due to immunosenescence and 
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the longer time that it takes an aged host to clear infection [118, 119], a prolonged sickness 
response in the aged may be actually benefit recovery. 
To examine if exercise affected brain pro-inflammatory cytokine expression 
independently of sickness behavior, we analyzed brain TNF-α, IL-1β, IL-6 and IL-10 gene 
expression 24h post LPS injection. We observed an LPS-induced upregulation of TNF-α, IL-1β 
and IL-10 gene expression in the brain, but no upregulation of IL-6. Furthermore, VWR 
intervention did not reduce the LPS-induced expression of TNF-α, IL-1β, or IL-10 in the brain, 
corroborating our negative sickness behavior findings.   
Peripheral cytokines act through various communication pathways to induce a ‘mirror 
image’ of cytokine expression within the brain (Dantzer & Kelley, 2007; Dantzer et al., 2008). 
Because acute exercise studies have demonstrated inhibition of LPS-induced TNF-  peripherally 
[120, 121], we investigated if 10 wks of VWR could reduce peripheral proinflammatory cytokine 
gene expression in response to LPS. As in the brain, we found no differences in LPS-induced 
cytokine gene expression in the spleen and liver of VWR, Locked, and Standard housed mice 
when measured 24h after LPS injection.  
While we observed no effects of VWR on pro-inflammatory cytokine expression in the 
brain or periphery, we did find an interesting disconnect between the brain and the periphery. At 
24h post-injection, we failed to see a LPS-induced up-regulation of IL-6 in the brain, whereas 
IL-6 was the highest expressed cytokine in the periphery.  The most logical explanation for this 
is the temporal course of cytokine expression after immune challenge, where TNF-  and IL-1  
rapidly increase, followed later by an increase in IL-6. Our data suggest central cytokine gene 
expression lags behind peripheral cytokine gene expression following i.p. LPS, and supports 
previous work demonstrating that brain IL-6 is not necessary for the observed sickness response 
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[122]. While we cannot speculate if IL-6 would demonstrate a VWR x LPS interaction at a later 
time-point, it is intriguing to propose it could be the case, given the finding by Funk et al who 
demonstrated VWR-induced IL-6 in the brain is responsible for neuronal protection following 
inflammatory insult [123].  
 While several studies have demonstrated that acute exhaustive or prolonged exercise can 
reduce inflammatory responses to LPS in mice (Tanaka et al., 2010) or humans (Starkie et al., 
2003), the effects of exercise training on LPS-induced inflammation and sickness behavior are 
sparse, controversial, and difficult to interpret due to differences in a number of variables 
including animal species, LPS dosage and route of administration, and exercise training modality 
and duration. Chen et al. [108] found 4 weeks of treadmill exercise training attenuated septic 
responses (including arterial pressure, neutrophil count, creatinine, blood urea nitrogen, blood 
liver enzymes) and reduced plasma TNF-α and IL-1β in response to LPS (10 mg/kg i.v.). In Type 
1 diabetic rats, 3 weeks of treadmill exercise training increased survival time and reduced serum 
TNF-α in response to LPS (15 mg/kg i.v.) when compared to sedentary controls [124].  In 
contrast, Rowsey et al [112] found that 8 weeks of exercise training increased the febrile 
response to LPS (0.05 mg/kg i.p.) in rats while having no effect on locomotor activity, while 
Criswell et al [110] found that 12 weeks of treadmill training increased serum TNF-α and β-
glucuronidase activity (5 mg/kg i.p). In hamsters administered LPS (0.01 mg/kg i.p.), there were 
no effects seen on serum IL-6 or febrile responses [109]. In regard to brain inflammation, Wu et 
al [113] demonstrated that 5 weeks of moderate treadmill running attenuated LPS-induced 
reductions in BDNF, its receptor TrkB, and alleviated LPS-induced cognitive dysfunction albeit 
not by reducing TNF-α and IL-1β 
independent of inflammation within the brain, were seen with LPS-induced dopaminergic neuron 
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loss in a model of Parkinson’s Disease [114]. In contrast, Nickerson et al. found VWR increased 
hypothalamic, pituitary, and dorsal vagal IL-1  protein in response to E. coli, while reducing 
circulating IL-1 , suggesting a training-induced disconnect between peripheral and central 
inflammatory responses [125]. Caution should be taken directly comparing the above-cited 
studies, as numerous reports have demonstrated differential peripheral and central training 
adaptations between treadmill training and voluntary wheel running [126, 127]. 
Much of the recent work on exercise’s neuroprotective effects have focused on BDNF as 
a primary mediator [128]. BDNF is a neurotrophin that acts primarily in the hippocampus, 
cortex, and basal forebrain to promote neurogenesis and synaptic plasticity. Inflammatory 
stimuli, such as LPS, reduce BDNF via an IL-1  dependent mechanism causing suppressed 
neurogenesis, neuron survival, and synaptic plasticity [62]. Numerous studies have demonstrated 
exercise training, in particular VWR, prevents the decrease in hippocampal BDNF and attenuates 
neuronal damage and cognitive impairment following inflammatory injury [113, 114]. Barrientos 
et al. elegantly demonstrated VWR protected aged rats from E. coli-induced cognitive 
impairments, and this was mediated by a reduction in hippocampal IL-1  and thus protection of 
BDNF [11]. Ex vivo stimulation of microglial from VWR rats revealed reduced sensitivity to 
LPS, suggesting a potential mechanism for VWR induced neuroprotection. Unfortunately, 
Barrientos et al. did not measure sickness behavior, and it is difficult to interpret their results in 
the context of our study paradigm (i.e. E. coli vs. LPS; cognitive vs. somatic). Indeed, little 
evidence supports a role for BDNF in the sickness response indicating exercise-induced 
protection of BDNF would unlikely influence sickness behavior. We found an LPS-induced 
reduction in whole brain BDNF, but no protective effect of wheel running on sickness behavior, 
demonstrating the exercise-induced up-regulation of BDNF shown in the literature is not a global 
 57 
 
event but rather a spatially dependent phenomenon predominately observed in the hippocampus. 
Although no studies have directly compared sickness behavior and cognition in exercise-trained 
animals, the data reporting beneficial effects of exercise on cognition have used working 
memory tasks, which are primarily hippocampal-dependent, whereas locomotor activity and 
sickness behavior are mediated by multiple brain regions including the hypothalamus, 
hippocampus, amygdala, and prefrontal cortex [96]. These observations support our hypothesis 
that appropriate sickness behavior is necessary for survival and is a robust stimulus that can’t be 
affected by exercise training.  
While our study clearly demonstrates no effect of voluntary wheel running on LPS-
induced sickness behavior in aged mice, we recognize certain limitations. Our study design did 
not assess brain and peripheral cytokine gene expression at all LPS doses or across numerous 
time-points. We chose to assess brain and peripheral tissue cytokine gene expression at 24h post-
0.33mg/kg LPS injection, based on observations by Godbout et al. demonstrating a clear age-
related difference in brain pro-inflammatory cytokine gene expression and sickness behavior 
between young and aged mice at that time point and dose [2]. Interestingly, our brain IL-6 gene 
expression data conflicts Godbout et al., who observed a robust increase 24h post-LPS injection. 
We speculate this is due to different mouse strains, as Godbout et al. used Balb/c mice, which are 
more sensitive to endotoxin compared to C57bl/6 mice, and thus, would be expected to exhibit a 
more robust cytokine upregulation (Silvia et al., 1990). Because we did not conduct a dose and 
time-course analysis of pro-inflammatory cytokine gene expression, we cannot definitively 
conclude that VWR had no effects on cytokine gene expression, and is possible subtle 
inflammatory effects may persist in the brain that are not reflected by behavioral measures. 
However, given that we performed the behavioral experiments first and there were no observed 
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VWR-induced changes in sickness behavior (our primary outcome), measuring cytokine gene 
expression at all LPS doses or across numerous time-points would be neither beneficial nor a 
worthwhile use of resources.  Additionally, whole brain IL-1  mRNA may not be the best 
measure given potential differences between IL-1  mRNA and protein levels due the role of the 
inflammasome and pro-IL-1  cleavage.  However, as stated above, because we found no 
differences in LPS-induced sickness behavior, we decided not to pursue IL-1  protein expression 
as we believe it contributes little to the overall findings of the study. Lastly, removing VWR 
mice from their wheels prior to LPS administration may be perceived as stressful to these 
animals. However, in order to correctly interpret our exercise training data without the influence 
of acute wheel running, this was necessary. 
In conclusion, we demonstrate that 10 weeks of voluntary wheel exercise training does 
not affect the LPS-induced exaggeration and prolongation of sickness behavior in aged mice, nor 
does it have any effect on LPS-induced pro-inflammatory cytokine gene expression in the brain 
or periphery 24h post 0.33mg/kg LPS injection. These data indicate that a sickness response 
(even if prolonged and exaggerated as it is in elderly) is likely important for survival and 
uninfluenced by prior exercise activity.  
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4.6 Figure Legends, Tables, and Figures 
 
Figure 4. Effects of VWR on LPS-induced changes in food intake in aged mice. LPS 
administration (a: Saline, b: 0.02 mg/kg LPS, c: 0.08 mg/kg LPS, d: 0.16 mg/kg LPS, and e: 0.33 
mg/kg LPS) resulted in significant (*) reductions in food intake, but there were no intervention 
main effects or intervention by treatment interactions at any LPS dose. Mean + sem; n = 23-28 
for Saline groups, and n=8-13 for all LPS groups. 
Figure 5. Effects of VWR on LPS-induced changes in fluid intake in aged mice. LPS 
administration (a: Saline, b: 0.02 mg/kg LPS, c: 0.08 mg/kg LPS, d: 0.16 mg/kg LPS, and e: 0.33 
mg/kg LPS) resulted in significant (*) reductions in fluid intake, but there were no intervention 
main effects or intervention by treatment interactions at any LPS dose. Mean + sem; n = 23-28 
for saline groups, and n=8-13 for all LPS groups. 
Figure 6. Effects of VWR on LPS-induced changes in body weight in aged mice. LPS 
administration (a: Saline, b: 0.02 mg/kg LPS, c: 0.08 mg/kg LPS, d: 0.16 mg/kg LPS, and e: 0.33 
mg/kg LPS) resulted in significant (*) reductions in body weight, but there were no intervention 
by treatment interactions at any LPS dose. VWR saline-treated mice exhibited significantly 
higher post-injection body weights at 8h compared to both Locked (*) and Standard saline-
treated mice (^) at 72, 96, and 168h. Mean + sem; n = 23-28 for saline groups, and n=8-13 for all 
LPS groups. 
Figure 7. Effects of VWR on LPS-induced reductions in locomotor activity (line crosses) in 
aged mice. LPS administration (a: Saline, b: 0.02 mg/kg LPS, c: 0.08 mg/kg LPS, d: 0.16 mg/kg 
LPS, and e: 0.33 mg/kg LPS) resulted in significant (*) reductions in locomotor activity in all 
intervention groups, but there was no intervention main effect or intervention by treatment 
interaction at any LPS dose. Mean + sem; n = 23-28 for saline groups, and n=8-13 for all LPS 
groups. 
Figure 8.  Effect of VWR on LPS-induced brain cytokine and BDNF mRNA expression 24h 
post-injection. LPS administration (0.33 mg/kg i.p.) resulted in significant (*) up-regulation of 
TNF , IL-1 , and IL-10 and a significant (*) down-regulation of BDNF. There were no 
significant intervention main effects or intervention by treatment interaction effects for any gene 
measured. IL-6 mRNA expression was unaffected by LPS or VWR. Mean + sem; n = 8-
14/group. 
Figure 9. Effect of VWR on LPS-induced peripheral tissue inflammatory gene expression 
in (a) spleen, and (b) liver 24h post-injection. LPS administration (0.33 mg/kg i.p.) resulted in 
significant (*) upregulation of IL-1  and IL-6 in spleen and liver. TNF-
significantly (*) elevated in response to LPS in liver and significantly (*) reduced in spleen. 
Mean + sem; n = 8-14/group 
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Distance 
Run 
(km/d) 
Pre-
Intervention 
Body Weight 
(g) 
Post-
Intervention 
Body Weight 
(g) 
Body 
Weight 
Change 
(%) 
Forced 
Exercise 
Time-to-
Fatigue 
(minutes) 
Epididymal 
Adipose 
Weight  
(% Body 
Weight) 
Voluntary 
Wheel 
3.54 ± 0.22 34.78 ± 0.38 32.35 ± 0.29 
-6.88 ± 
0.61
 a
 
82.89 ± 
5.89
 a
 
1.46 ± 0.16
 a
 
Locked 
Wheel 
---- 34.53 ± 0.35 33.38 ± 0.28 
-3.42 ± 
0.47
 b
 
38.27 ± 
3.00 
2.10 ± 0.28 
Standard ---- 33.75 ± 0.45 33.15 ± 0.34 
-.332 ± 
0.57 
26.90 ± 
3.36 
2.16 ± 0.28 
Table 1.  Intervention-induced adaptations and body composition changes. 
Mean ± SEM. 
a
 Significantly (p<0.05) reduced compared to Locked-Wheel and Standard housing 
conditions. 
b 
Significantly different compared to Standard housing condition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  Mortality in aged mice across intervention and LPS dose. 
Numbers represent: # deaths/ # total mice in group; time of each death. 
 
 
    LPS Dose  
 Saline  0.02 mg/kg 0.08 mg/kg 0.16 mg/kg 0.33 mg/kg 
Voluntary 
Wheel 
0/28  
2/10 (24h, 
48h) 
2/10 (72h, 
96h) 
2/10 (120h, 
120h) 
1/11 (72h) 
Locked 
Wheel 
0/28  0/9 
2/11 (24h, 
96h) 
0/10 3/13 (72h, 96h, 120h) 
Standard 0/27  0/9 
2/8 (24h, 
120h) 
1/11 (120h) 4/11 (8h, 8h, 24h, 96h) 
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 63 
 
Figure 6. 
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         CHAPTER 5 
 
VOLUNTARY WHEEL RUNNING DOES NOT AFFECT LIPOPOLYSACCHARIDE-
INDUCED DEPRESSIVE-LIKE BEHAVIOR IN YOUNG ADULT AND AGED MICE
3
 
 
5.1 Abstract 
Peripheral stimulation of the innate immune system with lipopolysaccharide (LPS) causes 
prolonged depressive-like behavior in aged mice that is dependent on indoleamine 2,3 
dioxygenase (IDO) activation.  Regular moderate intensity exercise training has been shown to 
exert neuroprotective effects that might reduce depressive-like behavior in aged mice.  The 
purpose of this study was to test the hypothesis that voluntary wheel running would attenuate 
LPS-induced depressive-like behavior and brain IDO gene expression in 4-month-old and 22-
month-old C57BL/6J mice. Mice were housed with a running wheel (Voluntary Wheel Running, 
VWR) or no wheel (Standard) for 30 days (young adult mice) or 70 days (aged mice), after 
which they were intraperitoneally injected with LPS (young adult mice: 0.83 mg/kg; aged mice: 
0.33 mg/kg). Young adult VWR mice ran on average 6.9 km/day, while aged VWR mice ran on 
average 3.4 km/day. Both young adult and aged VWR mice increased their forced exercise 
tolerance compared to their respective Standard control groups.  VWR had no effect on LPS-
induced anorexia, weight-loss, increased immobility in the tail suspension test, and decreased 
sucrose preference in either young adult or aged mice.  Four (young adult mice) and twenty-four 
(aged mice) hours after injection of LPS transcripts for TNF-α, IL-1β, IL-6, and IDO were 
upregulated in the whole brain independently of VWR.  These results indicate that prolonged 
                                                        
3 This chapter is used with permission of the co-authors: R. Dantzer, K.W. Kelley, J.A. Woods. 
 68 
 
physical exercise has no effect on the neuroinflammatory response to LPS and its behavioral 
consequences 
 
5.2 Introduction 
Major Depressive Disorders (MDD) are a multi-factorial set of psychiatric disorders with 
varying symptomatology and presumably, etiologies. Common symptoms include: depressed 
mood, reduced energy, loss of pleasure (anhedonia), dysregulated sleep and appetite, and 
feelings of guilt and/or suicide.  The worldwide prevalence of depressive disorders is ~15% in 
adults, and upwards of ~ 20% in adults over the age of 65. [47, 129, 130].  Further compounding 
the age-associated risk of MDD, older adults exhibit longer durations of depressive symptoms 
compared to young adults, and often suffer less dramatic depressive symptoms that go 
undiagnosed as merely a “consequence” of aging, yet significantly reduce social interactions and 
quality of life [45, 131, 132].  
The mechanisms of age-related depression are not fully elucidated, but several lines of 
evidence indicate inflammation can be a driving factor [39].  Aging is associated with chronic 
low-level inflammation, a condition known as ‘inflammaging’ (Franceschi, 2007).  Indeed, 
apparently healthy subjects >65 years old exhibit significantly elevated circulating C-reactive 
protein (CRP) levels compared to healthy young adults [133, 134].  The relationship between 
chronic inflammation and increased prevalence of depression is highlighted by the strong 
correlations between symptoms of depression and CRP and IL-6 levels in older adults [133, 
134].  In addition to inducing a chronic low-level of systemic inflammation, aging sensitizes the 
brain to subsequent immune stimuli such as infections and inflammatory stimuli [48].  Microglia 
cells from aged mice are primed in the sense they exhibit exaggerated and prolonged pro-
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inflammatory cytokine production following stimulation with lipopolysaccharide (LPS). This 
age-associated priming results in numerous behavioral consequences [48].  For example, 
peripheral injection of LPS lengthens the duration of sickness behavior (i.e. anorexia, weight 
loss, lethargy) in aged mice compared to young adult mice, and this is associated with an 
exaggerated and prolonged up-regulation of brain IL-1 , TNF- , and IL-6 [59, 94].   
Aged mice also exhibit greater sensitivity to inflammation-induced depressive-like 
behavior, which is related to the activity of the tryptophan degrading enzyme indoleamine 2,3 
dioxygenase (IDO).  IDO is the initial and rate-limiting enzyme of tryptophan catabolism 
through the kynurenine pathway [39, 41].  Activation of IDO is a required step in the 
development inflammation-induced depressive-like behavior [37, 43, 44].  Aging is associated 
with prolonged duration of IDO activation in response to inflammatory stimuli, resulting in 
protracted depressive-like behavior [58]. The same results are obtained in aged mice inoculated 
with Bacillus Calmette-Guérin (Kelley et al., 2013).   
The increased prevalence and burden of MDD is partially due to suboptimal treatment 
options [95].  The current protocol for treating age-related depression involves antidepressant 
therapies (e.g. tricyclic antidepressants and serotonin-selective reuptake inhibitors), which are 
moderately effective, but do not completely address the underlying inflammatory 
pathophysiology.  Furthermore, a significant percentage of patients are non-responders to 
currently available drugs [135]. Thus, there continues to be a major need to identify safe, 
alternative approaches for treating depression and reducing inappropriate neuroinflammation. 
Regular, moderate-intensity aerobic exercise may be one approach to alleviate depressive 
symptom burden in older adults. The mood enhancing benefits of cardiovascular exercise have 
been well documented in the literature and through the anecdotal testimony of thousands of 
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exercisers. Cross-sectional studies demonstrate an association between a high amount of physical 
activity and a low amount of depressive symptoms in both middle-aged and aged populations 
[72]. For example, we found that depressive symptoms were related to low physical activity, low 
aerobic fitness, high CRP, and adiposity in elderly women [70]. Furthermore, physical exercise 
might be especially efficient in reducing depressive symptoms among patients with mild to 
moderate depression, which is important because a large fraction of older adults (10-20%) have 
clinically significant depressive symptoms that do not meet the criteria for major depression 
[136]. It is plausible that exercise interventions could be utilized in these individuals, in the 
absence of pharmacological therapy, to mitigate depressive symptoms. Sjosten and Kivela 
(2006) conducted a meta-analysis of published randomized clinical trials to determine the 
strength of an effect of regular exercise on depression in older adults, and concluded exercise 
was effective in treating depression among those suffering from minor or major depression and 
reducing depressive symptoms in those with significant depressive symptoms at baseline [72].  
There are many unsubstantiated but potential ways in which exercise may improve mood and 
reduce depressive symptoms, including increased brain derived neurotrophic factor (BDNF), 
insulin growth factor (IGF), hippocampal neurogenesis, and anti-inflammatory effects [90, 137-
140]. Unfortunately, no studies have examined whether exercise training can attenuate 
inflammation-induced depressive like behavior in young adult and aged mice using a defined 
inflammatory stimulus.  
Therefore, we sought to examine the influence of voluntary wheel running (VWR) on 
LPS-induced depressive-like behavior and IDO activation in young adult mice and aged mice.  
We hypothesized that VWR would induce anti-inflammatory effects and attenuate LPS-induced 
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depressive-like behavior and brain proinflammatory cytokine and IDO gene expression in both 
young adult and aged mice.   
 
5.3 Materials and Methods 
Due to significant phenotypic differences between young adult and aged mice, such as 
the training duration necessary to induce metabolic adaptations and their endogenous sensitivity 
to LPS [58-60, 141], and the fact that the young adult and aged mice were obtained from two 
different sources, we conducted two separate and different experiments in the young and aged 
mice. Therefore, the data from the young adult mice and aged mice cannot be directly compared. 
Our purpose for this study design was not to examine the aging effect, which is already well 
documented [58-60], but rather to determine whether regular exercise can attenuate LPS-induced 
depressive like behavior under the optimal experimental conditions for each age category.  For 
this paper, we designate these two experiments as Experiment 1 (young [4 months] adult mice) 
and Experiment 2 (aged [19 months] mice).   
 
Animals 
All experiments were conducted under the guidelines of the University of Illinois, Urbana-
Champaign Institutional Animal Care and Use Committee. 
Experiment 1 (Young Adult Mice):  Four month-old male C57BL/6J mice (N=40) were 
obtained from the Jackson Labs (Bar Harbor, Maine), and singly housed in cages with corn-cob 
bedding in a temperature (23°C) and humidity (45-55%) controlled environment with a 12h 
dark/light cycle (lights off 0900-2100). Mice were allowed ad libitum access to food and water 
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for the entire duration of the study and were given 2 weeks to acclimate to the housing 
conditions prior to study commencement.  
Experiment 2 (Aged Mice): Nineteen month-old C57BL/6 mice (N=40) were obtained from the 
National Institute of Aging (Bethesda, MD) singly housed in cages with corn-cob bedding in a 
temperature (23°C) and humidity (45-55%) controlled environment with a 12h dark/light cycle 
(lights off 0900-2100). Mice were allowed ad libitum access to food and water for the entire 
duration of the study and were given 2 weeks to acclimate to the housing conditions prior to 
study commencement.  
 
Voluntary Wheel Training  
Experiment 1 (Young Adult Mice): Following acclimation, mice were randomized to a 
voluntary wheel running (VWR) or ‘normal’ (Standard) housing condition for a duration of 30 
days, which is sufficient time to induce training associated metabolic adaptations (unpublished 
data).  The VWR mice were individually housed in plexiglass cages (36 L  20 W  15 H cm) 
that contained a stainless steel running wheel (diameter 22.86 cm) (Mini-Mitter Repironics, 
Bend, OR).  Wheel revolutions were relayed via telemetry to a computer in the facility.  Standard 
mice were housed in smaller cages (30 L  19 W  13 H cm) without any type of environmental 
enrichment. 
Experiment 2 (Aged Mice): Exercise training adaptations occur more slowly in aged mice 
compared to younger mice due to the lower volume of daily running and metabolic differences 
(Derbre et al., 2012). Therefore, aged mice were randomized to VWR or Standard housing 
condition for a duration of 70 days, which is sufficient time to induce training associated 
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metabolic adaptations in aged mice [94]. All other aspects of the intervention were identical to 
Experiment 1.  
 
Treadmill Running Test  
Experiment 1 (Young Adult Mice): To assess VWR-induced training adaptations, we measured 
forced exercise fatigability on day 26 of the 30-day VWR intervention. Mice ran until exhaustion 
on a motor-driven treadmill at 5% grade at gradually increasing speeds from 10-26 m/min. 
Exhaustion was defined as the point at which mice refused to run despite prompting by mild 
prodding with the hand for a period of 10 s; electric shock was not used in this test.  
Experiment 2 (Aged Mice): To assess VWR-induced training adaptations in aged mice, we 
measured forced exercise fatigability on day 65 of the 70-day VWR intervention. Mice ran until 
exhaustion on a motor-driven treadmill at gradually increasing speeds from 6-21m/min. As 
above, exhaustion was defined as the point at which the mouse refused to run despite prompting 
by mild prodding with the hand for a period of 10 s; electric shock was not used in this test.  
 
LPS administration 
Given that aged mice exhibit a greater sensitivity to LPS-induced neuroinflammation and 
behavioral disturbances [58-60], we used different LPS doses for Experiments 1 and Experiment 
2. Based upon our preliminary data (not shown), both doses represent the minimum effective 
dose capable of inducing depressive-like behavior in the respective age cohorts of C57bl/6 mice. 
As rationale, we reasoned that if an exercise effect would be found it would be found at the 
minimum effective dose of LPS.  
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Experiment 1 (Young Adult Mice): After 30 days of VWR training, mice were randomized and 
injected intraperitoneally (i.p.) with saline or Escherichia coli LPS (lot 3129, serotype 0127:B8, 
Sigma) at a dose of 0.83 mg/kg.  To control for any effects of acute wheel exercise on LPS 
response, we injected mice 11 h after the end of their dark cycle on the final day of training. 
Thus, injection occurred during the final hour of the proceeding light cycle, a time-period where 
very little VWR occurs. Following injection, mice were placed back into their respective home 
cages. 
Experiment 2 (Aged Mice): Following 70 days of VWR training, aged mice were randomized 
and injected intraperitoneally (i.p.) with saline or Escherichia coli LPS (lot 3129, serotype 
0127:B8, Sigma) at a dose of 0.33 mg/kg.   As above, acute effects of wheel exercise were 
controlled for by injecting mice with LPS 11h after the end of their dark cycle on the final day of 
training.  
 
Measurement of sickness response.  
To ensure LPS had the intended effect, physiological sickness responses were assessed by 
changes in body weight and food intake.  Decreased food intake and the resulting body mass loss 
are sensitive measures of sickness in animals, and dependent on pro-inflammatory cytokine 
expression [14]. 
Experiment 1 (Young Adult Mice): Body weight and food intake were measured at 24 h post-
injection and calculated as the change from pre-injection baseline. 
Experiment 2, (Aged Mice): Body weight and food intake were measured at 24 h and 48 h post-
injection and calculated as the change from pre-injection baseline. 
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Measurement of depressive-like behavior  
Tail Suspension Test: Given that aged mice exhibit prolonged depressive-like behavior 
compared to young mice [58], we measured TST immobility at 24 h post-injection in Experiment 
1, and at 48 h post-injection in Experiment 2.   The tail suspension test (TST), a standardized test 
of depressive-like behavior in which depression is inferred from increased duration of 
immobility, was conducted as previously described [43]. Briefly, mice were taken from their 
home cage and hung from their tail on a hook connected to a strain gauge for a period of 6 
minutes (360 sec). A computerized system for processing the force exerted on the gauge (Mouse 
Tail Suspension Package, MED-TSS-MS; Med Associates, St Albans, VT, USA) collected and 
analyzed the movements of each individual mouse. An immobility threshold was determined by 
establishing an activity level that would exclude all movements and only encompass immobility. 
Time below this threshold indicated the time of immobility. 
 
Sucrose Preference Test:  Anhedonia is a key component of depression, and can be measured in 
mice by their preference to consume a sweetened solution. A sucrose preference test was 
performed following a 3 day acclimation program during the 24h period following LPS 
administration. As LPS-induced decreased sucrose preference resolves by 24h in both young 
adult and aged mice (unpublished data), this was the only time period measured for both 
Experiment 1 and Experiment 2. Mice were presented with two identical volumetric drinking 
tubes containing either water or a 1% sucrose solution. Drinking tubes were weighed before and 
after the 24h period to measure fluid consumption of each respective solution. Drinking tube 
position (right v. left) was alternated each training period to reduce potential bias from place 
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preference. Sucrose preference was calculated using the following formula: [Sucrose 
intake / (water intake + sucrose intake)] × 100. 
 
Tissue Collection 
Experiment 1 (Young Adult Mice): A separate group of mice underwent an identical training 
intervention and LPS treatment as Experiment 1, but instead of behavioral testing mice were 
killed by CO2 exposure at 4 h post- injection for tissue collection to examine pro-inflammatory 
cytokine and IDO gene expression. This time-point was chosen based on previous data indicating 
it as the peak of pro-inflammatory cytokine and IDO gene expression [142].   Tissues were 
dissected out after transcardial perfusion with ice-cold PBS saline. 
Experiment 2, (Aged Mice): A separate group of mice underwent an identical training 
intervention and LPS treatment as Experiment 2, but instead of behavioral testing mice were 
killed by CO2 exposure at 24 h post- injection for tissue collection to examine pro-inflammatory 
cytokine and IDO gene expression. This time-point was chosen based on data by Godbout et al. 
indicating it as the critical time-point of prolonged pro-inflammatory cytokine and IDO gene 
expression, differentiating the aged and young adult neuroinflammatory response [58]. 
 
RNA extraction and reverse transcription and Real-Time RT-PCR 
Total RNA from whole brain was extracted with Qiagen RNeasy Mini Kits (Valencia, CA).  
Reverse transcription reactions were completed in an Eppendorf Mastercycler Thermocycler 
(Hamburg, Germany) using an Applied Biosystem (Foster City, CA) High Capacity reverse 
transcriptase kit with 2,000 ng total RNA and random primers for each reaction. Quantitative 
real-time reverse transcription PCR was performed on an Applied Biosystems Prism 7900 using 
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TaqMan gene expression assays for TNF-  (Mm0043258_m1), IL-1  (Mm00434228_m1), IL-6 
(Mm00446190_m1), IL-10 (Mm00439616_m1), BDNF (Mm01334042_m1),  IDO 
(Mm00492586_m1) and glyceraldehyde 3-phosphate dehydrogenase (Mm999999_g1) purchased 
from Applied Biosystems (Foster City, CA).  Reactions were performed in duplicate according 
to the manufacturer’s instructions. Relative quantitative measurement of target gene expression 
was conducted using the Ct method with glyceraldehyde 3-phosphate (GAPDH) as the 
endogenous house-keeping gene and Standard+saline treated mice were used as the referent 
group. We chose to analyze TNF- , IL-1 , IL-6, IL-10, and IDO because they are critical 
mediators of inflammation-induced sickness and depressive-like behavior in mice [2, 96, 97]. 
BDNF is a critical neurogenic and anti-inflammatory growth factor that is highly influenced by 
exercise [143]. Our group has shown that inflammatory stimuli such as LPS can reduce brain 
BDNF [87, 88]. 
 
Statistical Analysis 
 Data from Experiment 1 and Experiment 2 were analyzed independently using SPSS v18 
(Chicago, IL). All data were normally distributed as determined by the Shapiro-Wilk test. 
Exercise-induced differences in body weight and fatigability were detected using an independent 
sample t-test (VWR versus Standard). Exercise-induced differences in behavioral and gene 
expression responses to LPS were detected using a 2 (VWR vs. Standard) x 2 (Saline vs LPS) 
ANOVA with repeated measures when necessary. Any reference to “groups” implies the 
following: (VWR+Saline, VWR+LPS, Standard+Saline, Standard+LPS). Data are expressed as 
mean  SEM. The alpha level was set at p < 0.05 and all tests were two-tailed. When 
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appropriate, between-group differences were determined using Fisher’s least significant 
difference post-hoc multiple pairwise comparisons. 
 
 
5.4 Results 
Effects of VWR on body weight and fatigability 
Experiment 1 (Young Adult Mice): There were no statistically significant differences in 
baseline body weights between exercise conditions (t36=-0.31, p=0.76) (Table 3). Young adult 
VWR mice ran an average of 6.91 + 0.25 km per day (Table 3), and there were no differences in 
daily running distance between young adult VWR+Saline and young adult VWR+LPS groups 
(t18=1.4, p=0.18).  As a result of increased energy expenditure due to VWR, young adult VWR 
mice gained less body weight compared to young adult Standard mice (time x exercise: F1,36= 
15.8, p=0.00) (Table 3). There were no differences in body weight change (t18=-0.06, p=0.96) 
between VWR+Saline and VWR+LPS mice.  To assess VWR-induced improvements in muscle 
endurance, we subjected all young adult mice to a forced treadmill exercise test to exhaustion. 
Young adult VWR mice ran the longest before reaching exhaustion, running approximately 50% 
longer than young adult Standard mice, indicating that the 30-day VWR protocol induced the 
expected metabolic adaptations responsible for improved endurance performance (intervention: 
t33=-2.7, p=0.01) (Table 3). There were no differences in forced exercise performance (t18=-0.80, 
p=0.44) between young adult VWR+Saline and young adult VWR+LPS mice. 
 
Experiment 2 (Aged Mice): There were no statistically significant differences in baseline body 
weights between exercise conditions (t33=-0.24, p=0.81) (Table 3). Aged VWR mice ran an 
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average of 3.40 + 0.40 km per day (Table 3), and there were no differences in daily running 
distance between aged VWR+Saline and aged VWR+LPS groups (t16=-0.98, p=0.33).  Aged 
VWR mice lost more body weight compared to aged Standard mice (time x exercise: F1,33=15.1, 
p=0.00) (Table 3), and ran significantly longer before reaching exhaustion, indicating the 
efficacy of the 70 d VWR protocol (intervention: t33=-4.7, p=0.00) (Table 3). There were no 
differences in body weight change (t16=0.64, p=0.53) or forced exercise performance (t16=0.92, 
p=0.37) between aged VWR+Saline and aged VWR+LPS mice. 
 
Effects of VWR on LPS-induced brain gene expression 
Experiment 1 (Young Adult Mice): We investigated whether VWR could mitigate LPS-
induced gene expression changes in the brains of young mice 4 h post-injection (Figure 10a). 
LPS administration resulted in a significant increase in whole brain TNF- , IL-1 , IL-6, and 
IFN-  mRNA (treatment: F1,32=100.0, p=0.00; F1,32=76.7, p=0.00; F1,32=60.8, p=0.00; F1,32=32.6, 
p=0.00 for TNF- , IL-1 , IL-6, and IFN- , respectively), which was not attenuated by VWR 
(intervention x treatment interaction: F1,32=0.54, p=0.47; F1,32=0.69, p=0.41; F1,32=00, p=0.99; 
F1,32=0.89, p=0.35 for TNF- , IL-1 , IL-6, and IFN- , respectively) (Figure 1e). Similarly, LPS 
significantly upregulated IDO gene expression (treatment: F1,32=27.3, p=0.00), which was also 
not altered by VWR (intervention x treatment: F1,32=1.2, p=0.28).  VWR, as applied in this study, 
could not attenuate the LPS-inducted reduction in brain BDNF mRNA expression (intervention x 
treatment F1,32= 1.98; p = 0.17).  There were no intervention main effects (p’s for intervention 
main effects = 0.50, 0.41, 0.99, 0.28, 0.99, and 0.36 for TNF- , IL-1 , IL-6, IDO, IFN- , and 
BDNF, respectively). These data support our findings of a lack of effect of VWR on sickness and 
depressive-like behavior induced by LPS in young adult mice.  
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Experiment 2 (Aged Mice): At 24h post-injection, LPS administration resulted in a significant 
increase in whole brain TNF- , IL-1 , and IL-6 mRNA,(treatment: F1,36=36.2, p=0.00; 
F1,36=46.3, p=0.00; F1,36=9.2, p=0.005 for TNF- , IL-1 , and IL-6, respectively), none of which 
were attenuated by VWR (intervention x treatment interaction: F1,36=0.63, p=0.43; F1,36=0.30, 
p=0.59; F1,32=0.07, p=0.80 for TNF- , IL-1 , and IL-6, respectively) (Figure 11a). LPS 
significantly upregulated brain IDO (treatment: F1,36=12.0, p=0.01), which was not affected by 
VWR (intervention x treatment: F1,36=0.004, p=0.98).  LPS did not significantly increase whole 
brain IFN-  at 24h post-injection (treatment: F1,36=1.6, p=0.21).  Additionally, VWR, as applied 
in this study, could not attenuate the LPS-induced reduction in brain BDNF mRNA expression 
(intervention x treatment F1,36= 376; p = 0.54). There were no intervention main effects (p’s for 
intervention main effects = 0.74, 0.58, 0.68, 0.95, and 0.51 for TNF- , IL-1 , IL-6, IDO, and 
BDNF, respectively). Interestingly, however, there was a main effect for IFN- , in that VWR 
training reduced whole brain IFN-  mRNA expression (intervention: F1,36=4.34, p=0.04). 
Collectively, these data support our findings of a lack of effect of VWR on sickness and 
depressive-like behavior induced by LPS in aged mice. 
 
Effects of VWR on LPS-induced sickness responses 
Experiment 1 (Young Adult Mice): As expected, LPS injection resulted in a significant 
reduction in food intake compared to young adult saline-injected mice at 24 h post-injection 
(time x treatment: F1,32=43.7, p=0.00), but there were no statistically significant differences 
between groups (time x exercise x treatment: F1,32=0.08, p=0.78) (Figure 10b). There was no 
difference food intake between young saline-injected VWR and Standard mice (time x 
intervention: F1,32=0.58, p=0.45). As a result of LPS-induced anorexia, all young adult LPS-
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injected mice lost statistically significant amounts of body weight during the 24 h post-LPS (time 
x treatment: F1,32=36.8, p=0.00), and there were no significant differences between VWR and 
Standard housed mice in response to LPS (time x intervention x treatment: F1,32=0.19, p=0.67) 
(Figure 10c). There was no difference in body weight changes between young adult saline-
injected VWR and Standard mice (time x intervention: F1,32=0.44, p=0.51).  
Experiment 2 (Aged Mice): Like young adult LPS-injected mice, aged LPS-injected mice 
exhibited a significant reduction in food intake at 24 h and 48 h post-injection compared to aged 
saline-injected mice (time x treatment: F2,60=36.9, p=0.00), but there was no significant effect of 
VWR training (time x intervention x treatment (F2,60=0.1, p=0.93) (Figure 11b). There was no 
difference in food intake between aged saline-injected VWR and Standard mice (time x exercise: 
F2,60=0.43, p=0.65), nor was there an exercise main effect (exercise: F1,30=0.5, p=0.49).  Aged 
LPS-injected mice lost significant body weight compared to aged saline-injected mice (time x 
treatment: F2,60=36.1, p=0.00), and there were no significant differences between VWR and 
Standard housed mice in response to LPS (time x exercise x treatment (F2,60=0.03, p=0.97) 
(Figure 11c). There was no difference in body weight changes between aged saline-injected 
VWR and Standard mice (time x exercise: F2,60=0.1, p=0.93), nor was there an exercise main 
effect (intervention: F1,30=0.04, p=0.83). 
 
Effects of VWR on LPS-induced depressive-like behavior 
Experiment 1 (Young Adult Mice): We assessed depressive-like behavior at 24 h post-LPS 
injection via the tail suspension test and sucrose preference test.  LPS significantly increased 
duration of immobility in the tail suspension test (treatment: F1,32=6.3, p=0.02), but there was no 
interaction (exercise x treatment interaction: F1,32=0.10, p=0.75) (Figure 10d). There were no 
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differences in baseline sucrose preference between groups (F3,32=0.15, p=0.93). LPS 
significantly decreased sucrose preference compared to baseline (time x treatment interaction: 
F1,32=5.97, p=0.02) , but exercise did not affect this (time x exercise x treatment interaction: 
F1,32=0.18, p=0.67) (Figure 10e). There were no exercise main effects (p’s for exercise main 
effects = 0.86 and 0.83, for TST and SPT, respectively). Taken together, these data indicate 
VWR training had no effects on LPS-induced depressive-like behavior in young adult mice.  
Experiment 2 (Aged Mice): We assessed depressive-like behavior via the decreased sucrose 
preference that is apparent at 24h post-injection and the increased duration of immobility that is 
measured in the tail suspension test at 48h post-injection. LPS significantly increased the 
duration of immobility (treatment: F1,32=19.2, p=0.00), but there was no interaction (exercise x 
treatment interaction: F1,32=0.00, p=0.96) (Figure 11d). There were no differences in baseline 
sucrose preference between groups (F3,34=0.83, p=0.49). LPS significantly decreased sucrose 
preference compared to baseline (time x treatment interaction: F1,32=8.9, p=0.006) , but exercise 
did not affect this (time x exercise x treatment interaction: F1,32=0.28, p=0.60) (Figure 11e). 
There were no exercise main effects (p’s for exercise main effects = 0.97 and 0.22, for tail 
suspension test and sucrose preference tests, respectively). Taken together, these data indicate 
VWR training had no effects on LPS-induced depressive-like behavior in aged mice. 
 
5.5 Discussion 
In Experiment 1 we investigated whether a voluntary wheel running intervention could 
attenuate LPS-induced depressive-like behavior in young adult mice. Thirty days of voluntary 
wheel running induced the expected training adaptations including reduced weight gain and 
increased forced treadmill exercise performance.  Regardless of treatment, young adult mice 
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injected with LPS exhibited a significant reduction in food intake, resulting in weight loss at 24 h 
post injection.  Contrary to our hypothesis, the measures of depressive-like behavior did not 
differ according to the exercise condition. To further support the lack of an exercise effect on 
LPS-induced depressive-like behavior, we analyzed brain proinflammatory cytokine and IDO 
gene expression, and found no significant wheel running effects.  
Because aging leads to exaggerated and prolonged inflammation and behavioral effects 
[58-60], in Experiment 2 we investigated whether a voluntary wheel running intervention could 
attenuate exaggerated and prolonged LPS-induced depressive-like behavior in aged mice. 
Similar to the effects observed in the young adult mice, the VWR training program induced body 
weight loss and increased forced exercise performance in aged mice indicating that it had its 
intended effects.  VWR and Standard housed mice injected with LPS exhibited a similar 
significant reduction in food intake, resulting in body weight loss at 24h and 48h post-injection. 
These data confirm our previous research demonstrating no beneficial effects of VWR on LPS-
induced sickness behavior across multiple LPS doses [94].  Contrary to our hypothesis, there 
were no differences in LPS-induced depressive-like behavior responses in the tail suspension test 
and the sucrose preference test between aged VWR and aged Standard mice, and VWR 
intervention did not attenuate brain IDO and/or proinflammatory gene expression in response to 
LPS. Taken together, these data show clearly that prolonged voluntary exercise in mice has no 
effect on the neuroinflammatory and behavioral response to LPS and this lack of effect is the 
same in both young adults and aged individuals. 
A potential explanation for our lack of significant findings could be an insufficient study 
sample size to detect between group differences. However, we conducted an a priori power 
analysis (type I and type II errors set at 5% and 80%, respectively) to determine the minimum 
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sample size necessary to observe a significant intervention x treatment interaction for our most 
variable measure, sucrose preference.  Based upon a thorough investigation of the literature 
examining the effects of exercise training on depressive-like behavior in rodent models, we 
determined that we would need 10 mice per group to detect a ~40-50% (effect size ~0.65) 
exercise-induced difference in the sucrose preference test [144].  Therefore, we believe our data 
reflect a lack of VWR effect rather than insufficient statistical power.  An alternative 
interpretation of our findings could be that our respective LPS doses were too high and masked 
any subtle benefits of VWR. However, as stated in the methods section, we utilized the minimum 
effective LPS dose necessary to induce depressive-like behavior in the respective mouse models.  
We previously examined the effects of VWR training on LPS-induced sickness behavior at a 
very low LPS dose  (0.02 mg/kg), and observed no protective effects of VWR [94], which lends 
further credence to the lack of effect within our current experiments. 
To the best of our knowledge, this is the first study to utilize a defined inflammatory 
challenge (i.e., LPS) to examine the effects of exercise training on inflammation-induced 
depressive-like behavior.  Several groups have investigated the effects of exercise training on 
unpredictable chronic mild stress-induced depressive-like behavior and neuroinflammation, and 
found promising results. Solberg et al. found 6 weeks of voluntary wheel running of mice in 
conjunction with six weeks of chronic stress increased sucrose preference and decreased FST 
immobility compared to mice that were exposed to chronic stress but without prior wheel 
training [145].  These results were similar to Zheng et al., who demonstrated four weeks of 
wheel training in conjunction with chronic mild stress recovered sucrose preference, which was 
associated with decreased hippocampal corticosterone (CORT) expression and increased 
hippocampal brain-derived neurotrophic factor (BDNF) expression [146]. Exactly how BDNF 
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may be mediating depressive-like behavior is unclear, but one possibility is that BDNF may be 
improving survival of neurons affected by chronic stress. Duman et al. proposed an alternative 
molecular mechanism; these authors discovered four weeks of wheel training increased 
prefrontal cortex insulin-like growth factor 1 (IGF-1), and this increase was associated with a 
protected sucrose preference and immobility in the forced swim test [147]. While this response 
appears to be inherently different than the BDNF hypothesis, data by Park et al. indicate IGF-1 
protects brain BDNF signaling during an inflammatory challenge [87, 88] . Therefore, it is 
plausible that exercise-induced IGF-1 could be mediating its anti-depressant effects via BDNF 
regulation. These studies support much of the recent work on exercise’s neuroprotective effects, 
which have focused on BDNF regulation within the hippocampus.  BDNF is a neurotrophin that 
acts predominantly in the hippocampus, cortex, and basal forebrain to promote neurogenesis, 
neuron survival, and synaptic plasticity.  Like LPS, chronic stress reduced BDNF via an IL-1β 
dependent mechanism causing suppressed hippocampal neurogenesis and neuron survival [148].  
Numerous studies have demonstrated exercise training upregulates hippocampal BDNF gene and 
protein expression, and this is associated with improved behavioral outcomes during 
inflammatory challenge. We observed an LPS-induced reduction in whole brain BDNF, but 
failed to detect a VWR-induced increase in whole brain BDNF gene expression in both our 
young adult and aged mice. This indicates the exercise-induced upregulation of BDNF as 
demonstrated in the literature is not a global event, but rather a spatially dependent phenomenon 
primarily observed in the hippocampus. 
More relevant to our specific aims, a recent study by Liu et al. examined the effects of 
swim training on depressive-like behavior and IDO activity in rats submitted to chronic mild 
stress [144].  Following 4 weeks of swim training in combination with chronic stress, swim 
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trained rats exhibited increased sucrose preference and decreased FST immobility compared to 
chronically stressed rats that did not swim train. Moreover, these behavioral results were 
associated with reduced prefrontal cortex IFN-γ, TNF-α, and IDO gene expression, indicating the 
protective effects of exercise training in this chronic stress model may be mediated by inhibiting 
IDO activation and metabolism.  In relation to our results, these data indicate that  depressive-
like behavior in response to chronic mild stress is amenable to the beneficial effects of VWR, 
whereas LPS-induced depressive-like behavior is not. Again, it is important to note that we 
utilized the minimum LPS dosage which induces depressive-like behavior in our models. What is 
unknown is whether other inflammatory stimuli, perhaps that act more chronically, are equally 
insensitive to VWR.  
A potential explanation for the differential findings between our study and those using 
chronic mild stress, is that LPS-induced depressive-like behavior is a well-defined acute 
phenomenon dependent on activation of the IDO pathway [43], while chronic mild stress-
induced depression is a chronic paradigm dependent on numerous cellular and molecular 
mechanisms (e.g., HPA axis dysregulation, aberrant monoamine signaling, and reduced growth 
factor synthesis) which synergize to induce a depressive-like behavior phenotype  [149]. Under 
basal conditions, IDO is expressed at low levels in microglial cells and astrocytes, with the 
majority of IDO activity occurring in astrocytes, and the primary end product being kynurenic 
acid, a neuroprotective NMDA antagonist [39, 41, 150].  However, following immune activation 
(e.g., LPS), proinflammatory cytokines TNF-  and IFN-  induce IDO activation in microglial 
cells, shifting kynurenine metabolism towards the production of 3-hydroxykynurenine (3-HK) 
and quinolic acid (QA), which are implicated in inflammation-induced depressive-like behavior 
[151]. An alternative explanation could be due to temporal differences in administration of 
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exercise and ‘inducer’ of behavioral disturbance. In chronic mild stress studies, exercise was 
performed chronically during the administration of the stressors, whereas in our study exercise 
was performed prior to LPS administration. Mice were not allowed wheel access after LPS as it 
has been shown that they do not run during this acute inflammatory challenge. This hypothesis 
concurs with the BDNF literature, which indicates exercise-induced BDNF improves neuron 
survival during stress, rather than protecting against acute inflammatory injury.  
Regarding the effects of exercise training on age-related neuroimmune alterations, 
several reports have demonstrated exercise may attenuate microglial priming.  Vukovic et al. 
found VWR training reduced hippocampal microglia MHCII expression and increased neuronal 
fractalkine (CX3CL1) in young mice [152].  Fractalkine binds to its receptor (CX3CR) on 
microglia and maintains the cell in a quiescent state. Following immune activation, fractalkine 
signaling is critical for attenuating the microglia inflammatory response and restoring brain 
inflammation to baseline levels. Several studies indicate aging reduces basal levels of fractalkine, 
which may partially explain microglial priming [48]. Furthermore, following a LPS challenge, 
microglia from aged mice exhibited a prolonged down-regulation of the fractalkine receptor 
compared to young mice, which may contribute to the prolonged proinflammatory cytokine 
response and protracted behavioral disturbances observed in aged mice. Kohman et al. 
demonstrated similar anti-priming effects of exercise in hippocampal microglia of aged mice.  
Eight weeks of VWR in aged Balb/c mice reduced microglia proliferation and microglia IGF-1 
gene expression [153].  Barrientos et al. further addressed the effects of exercise on microglia 
priming by isolating primary hippocampal microglia from the wheel trained and sedentary aged 
rats [21]. Following stimulation with numerous doses of LPS (0-100ng), the microglia from the 
voluntary wheel running rats exhibited a significantly reduced TNF-α and IL-1β gene expression 
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compared to microglia from rats housed in locked wheels, indicating that exercise training may 
‘reverse’ age-induced microglia priming and subsequent neuroinflammation. Interpreting this 
study in the context of ours is difficult, as ex vivo microglia stimulation occurs under tightly 
controlled and optimal experimental conditions. The researchers did not report the upper-limit 
LPS concentration where they observed no differences in microglia priming between wheel 
running and locked wheel rats.  It is quite possible that the minimum effective LPS doses we 
utilized to induce depressive-like behavior corresponded to a higher ‘stimulus’ than 100ng LPS 
applied to hippocampal microglia in vitro, thus abolishing any protective effect of exercise. 
Additionally, similar to the BDNF literature, these studies only examined the effects of exercise 
on hippocampal microglia priming, the brain region most affected by exercise training. Our lack 
of observed exercise induced neuroprotection in whole brain tissue furthers supports our 
hypothesis that exercise’s protective effects are not a global event, but rather a brain-region 
dependent phenomenon primarily observed in the hippocampus.  
  While our study clearly demonstrates no effect of voluntary wheel running on LPS-
induced depressive-like behavior in young adult and aged mice, we recognize certain limitations.  
We did not include a ‘locked’ wheel control group for the voluntary wheel intervention. It is 
plausible that any observed VWR effects could have been due to environmental enrichment 
rather than adaptations induced by the exercise component of wheel running.  However, we have 
previously reported no differences between VWR, locked wheel, and standard housing 
interventions on LPS-induced sickness behavior in aged mice [94].  Furthermore, Kobilo et al. 
elegantly demonstrated the act of running, rather than environmental enrichment, is responsible 
for neurotrophic effects of voluntary wheel running [154]. A second limitation is that our study 
design did not assess brain cytokine and IDO gene expression across numerous time-points, 
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which would strengthen our conclusion that voluntary wheel running does not affect LPS-
induced IDO induction and the subsequent depressive-like behavior. We chose to assess brain 
gene expression at the selected time-points based on observations that 4h post-injection was the 
peak of inflammation in young mice, and 24h post-injection was the critical time-point of 
prolonged pro-inflammatory cytokine and IDO gene expression, differentiating the aged and 
young adult neuroinflammatory response [58, 59].  Because we did not conduct a time-course 
analysis of brain cytokine and IDO gene expression, we cannot definitively conclude that VWR 
had no effects of neuroinflammation at the given doses of LPS, and it is possible that subtle 
inflammatory effects persist in the brain that are not reflected by behavioral outcomes.  
Similarly, we recognize whole brain analysis does not reveal potential exercise-induced 
neuroprotective regional differences, and thus can only speculate that exercise’s protective 
effects occur in a region specific manner. Given that depressive-like behavior was our primary 
outcome and there were no observed VWR-induced changes in depressive-like behavior, 
measuring brain cytokine and IDO gene expression at numerous time points and across 
numerous brain regions did not seem worthwhile in the context of our experiments.    
 In conclusion, we demonstrate that voluntary wheel exercise training does not 
affect LPS-induced depressive-like behavior, nor does it influence LPS-induced brain cytokine 
or IDO gene expression at 4h or 24h post-injection, in young adult and aged mice, respectively.  
These lack of neuroprotective effects occurred despite using the minimum effective doses and 
optimal behavioral time-points in our respective mouse models. Collectively, these data indicate 
the anti-depressant and neuroprotective effects of exercise are sensitive to the inflammatory 
stimulus utilized (i.e., LPS vs. CMS), and further research is necessary to elucidate the complex 
effects of exercise training on inflammation-induced depressive-like behavior. 
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5.6 Figure Legends, Tables, and Figures 
 
Figure 10. Effects of VWR on LPS-induced changes in sickness behavior, depressive-like 
behavior, and brain gene expression in young adult mice. LPS administration resulted in 
significant (*) up-regulation of TNF- , IL-1 , IL-6, IDO, and IFN-γ, and a significant (*) down-
regulation of BDNF at 4h post-injection (a). There were no significant intervention main effects 
or intervention by treatment interaction effects for any gene measured. LPS administration 
resulted in significant (*) reductions in food intake (b) and body weight (c), increased 24h TST 
immobility (d), and reduced 24h sucrose preference (e), but there were no intervention main 
effects or intervention by treatment interactions. Mean + sem; n = 9-10/group.  
 
Figure 11. Effects of VWR on LPS-induced changes in sickness behavior, depressive-like 
behavior, and brain gene expression in aged mice. LPS administration resulted in significant 
(*) up-regulation of TNF- , IL-1 , IL-6, and IDO and a significant (*) down-regulation of 
BDNF at 4h post-injection. There were no significant intervention main effects or intervention 
by treatment interaction effects for any gene measured (a). LPS administration resulted in 
significant (*) reductions in food intake (b) and body weight (c), increased 48h TST immobility 
(d), and reduced 24h sucrose preference (e), but there were no intervention main effects or 
intervention by treatment interactions. Mean + sem; n = 9-10/group.  
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Distance 
Run 
(km/d) 
Pre-
intervention  
body weight 
(g) 
Post-
intervention  
body weight 
(g) 
Body weight 
change (%) 
Forced 
exercise 
time- 
to-fatigue 
(minutes) 
Experiment 1:  
Young Adult Mice 
     
Voluntary  Wheel 6.91 ± 0.25 24.72 ± 0.56  24.58 ± 0.38 0.09 ± 1.9 a 58.5 ± 2.7 a 
Standard ----- 24.92 ± 0.23 26.45 ± 0.24 6.11 ± 0.47 47.29 ± 2.86 
Experiment 2:  
Aged Mice 
     
Voluntary Wheel 3.4 ± 0.4 33.07 ± 0.42 32.22 ± 0.49 -1.43 ± 1.20 b 75.7 ± 8.50 b 
Standard ----- 33.23 ± 0.50 33.30 ± 0.29 1.35 ± 0.77 33.34 ± 2.58 
Table 3. Intervention-induced adaptations. 
Mean ± SEM; n=9-10/group 
a
 Significantly (p < 0.05) reduced compared to Young Adult Standard housing conditions. 
b
 Significantly (p < 0.05) reduced compared to Aged Standard housing conditions. 
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Figure 11. 
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CHAPTER 6 
 
FORCED TREADMILL EXERCISE FOLLOWING BACILLUS CALMETTE-
GUÉRIN INFECTION PROLONGS THE SICKNESS RESPONSE IN YOUNG 
ADULT MICE
4
 
 
 
6.1 Abstract 
 
We tested the effects of daily forced treadmill exercise on BCG-induced sickness 
behavior in young adult mice balb/c mice.  Mice were intraperitoneally injected with BCG; 4 
hours later they underwent a 30-minute treadmill running bout or remained sedentary, and 
treadmill running continued for one session/day for the remainder of the study.  As expected, 
BCG induced significant anorexia, body weight loss, anhedonia via sucrose preference, and 
reduced voluntary wheel running.  BCG-infected mice forced to treadmill exercise post-
infection exhibited prolonged weight loss, reduced voluntary wheel running, and a tendency 
toward decreased sucrose preference compared to BCG-infected mice allowed to remain 
sedentary.  Treadmill exercise may act as a stressor, which reduces the efficacy of the 
immune response to BCG, decreases BCG clearance, and prolongs BCG-induced sickness 
behavior. 
 
 
 
                                                        
4 This chapter is used with permission of the co-authors: J.C. O’Connor , R. Dantzer, K.W. 
Kelley, J.A. Woods 
 
 100 
 
6.2 Introduction 
Peripherally and centrally produced cytokines act directly or indirectly on neurons and 
supporting cells (e.g., microglia and astrocytes) to alter autonomic nervous and endocrine system 
output to regulate the body’s response to infection [15]. Interleukin-1 beta (IL-1β), for example, 
induces activation of the hypothalamic-pituitary-adrenal axis and the production of 
corticosteroids, which attenuate the pro-inflammatory response in a negative feedback loop.  
Moreover, these cytokines propagate signals to various brain structures, including the 
hypothalamus, hippocampus, amygdala, and prefrontal cortex, to invoke a constellation of 
motivated behavioral adaptations, often termed ‘sickness behavior [15].’  Sickness behaviors 
include loss of appetite and body weight, fatigue, withdrawal from normal social activities, 
altered cognition, hyperalgesia, anhedonia, and fever.  Long believed to be a general weakness 
and malaise associated with infection, it is now realized the purpose of these adaptations is to 
allocate energy and resources towards the immune response and support recovery from infection. 
The importance of such behaviors was bolstered by powerful observations that inhibiting certain 
aspects of the sickness response resulted in decreased survival of infected animals [155-157].  A 
pioneering study by Murray et al. demonstrated forced tube feeding of anorexic sick mice to 
normal levels resulted in a doubling of mortality from  Listeria monocytogenes infection 
compared to mice allowed to eat ad libitum [156]. In a similar manner, animals housed in a cold 
environment or treated with an antipyretic drug displayed higher mortality rates following 
numerous infection types, suggesting an adequate febrile response is critical for host defense and 
survival [155, 157-160].   While these studies were conducted more than thirty years ago, it is 
now understood that sickness induced anorexia limits foraging behavior and nutrient available to 
 101 
 
invading pathogens, and the pyretic response blunts microorganism replication capacity and 
enhances immune cell effector mechanisms.   
As energy conservation and allocation toward the immune response is the primary goal of 
sickness behavior, it is fitting that a classical indicator of sickness is reduced locomotor activity.  
Animals injected with live viruses or bacteria, viral or bacterial mimetics (poly I:C or LPS), or 
proinflammatory cytokines (TNFa or IL-1B) exhibit a robust reduction in locomotor activity 
[94]. For example, young mice injected with LPS exhibit decreased home cage locomotor 
activity, as well as reduced exploration in a novel environment within an hour of inoculation. 
Similarly, young healthy balb/c mice injected with the attenuated bacterium Bacillus Calmette-
Guérin (BCG) reduce their voluntary wheel running activity to virtually nothing for 
approximately three days post-infection (unpublished data).  These observations prompted 
Skinner et al. to propose that avoidance of physical activity may be the most sensitive indicator 
of sickness [161].  Measuring fever (febrile response), food intake (anorectic response), and 
voluntary wheel running (locomotor response) following LPS injection across three doses in rats, 
the researchers discovered, via statistical regression analysis, that decreased voluntary wheel 
running was the most sensitive measure of the sickness response to LPS [161]. Given the 
energetic cost of locomotor activity, it makes logical sense on an evolutionary basis that 
proinflammatory cytokines produced during infection would act in the brain to limit locomotor 
and energy expenditure.  However, the importance of reduced locomotor activity during sickness 
has never been empirically demonstrated in a similar manner to the anorectic and febrile 
response.  
Therefore, the purpose of our study was to examine the effect of forced treadmill exercise 
(i.e. forced locomotor activity) on sickness behavior following BCG infection. We hypothesized 
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mice forced to treadmill exercise would exhibit prolonged sickness behavior and protracted 
recovery from infection. 
 
 
6.3 Materials and Methods 
 
Animals 
Four month-old male balb/c mice (N=40) were obtained from the Jackson Labs (Bar Harbor, 
Maine), and singly housed in cages with corn-cob bedding in a temperature (23°C) and humidity 
(45-55%) controlled environment with a 12h dark/light cycle (lights off 0900-2100). Mice were 
allowed ad libitum access to food and water for the entire duration of the study and were given 
two weeks to acclimate to the housing conditions prior to study commencement. All experiments 
were conducted under the guidelines of the University of Illinois, Urbana-Champaign Animal 
Care and Use Committee. 
 
Voluntary Wheel Running  
In contrast to our previous studies using voluntary wheel running (VWR) as an exercise training 
modality, in this study we used VWR as a measure of sickness behavior. As previously 
mentioned, mice infected with BCG significantly reduce their voluntary wheel running for ~3d 
post-infection.  Following facility acclimation, all mice were individually housed in a plexiglass 
cage (36 L  20 W  15 H cm) that contained a stainless steel  running wheel (diameter 22.86 
cm) (Mini-Mitter Repironics, Bend, Oregon).  Wheel revolutions were relayed via telemetry to a 
computer in the facility.  Ten days of baseline wheel running data was collected prior to BCG 
inoculation to account for individual running variability between mice.   
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Infection with Bacillus Calmette-Guérin 
Following ten days of baseline wheel running, mice were randomized and intraperitoneally 
injected with 10
8 
CFU BCG per mouse or equivolume saline. BCG is a live attenuated bacterium 
prepared from mycobacterium bovis, a strain of bovine tuberculosis bacillus [42].  It is 
commonly used, with little efficacy, in humans to vaccinate against human tuberculosis. 
Infection of mice with BCG is a well-validated model of chronic immune activation. Mice 
chronically infected with this dose of BCG display a robust chronic pro-inflammatory cytokine 
response and a resulting episode of sickness behavior which lasts a duration of ~6d. 
 
Forced Treadmill Exercise Protocol 
Beginning at 4h post-inoculation, mice were randomized to two intervention groups: forced 
treadmill exercise or sedentary. Forced treadmill mice were treadmill exercised once per day for 
thirty minutes at an intensity of 8-12m/m (60-70% VO2max), for nine days post-infection; 
sedentary exposed to the noise of the treadmill, and had their food and water removed for the 
same duration as the runners, but did not undergo forced treadmill running. 
 
Measurement of Sickness Behaviors 
Sickness behavior was assessed by changes in body weight, food and fluid intake, voluntary 
wheel running, and anhedonia via sucrose preference.  Body weight, food and fluid intake, and 
voluntary wheel running were measured for nine days post-injection.  Anhedonia is a key 
component of sickness behavior, and can be measured in mice by their preference to consume a 
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sweetened solution. A sucrose preference test was performed six days after BCG infection. Mice 
were presented with two identical volumetric drinking tubes containing either water or a 1% 
sucrose solution. Bottles were weighed before and after the 24h period to measure fluid 
consumption of each respective solution. Bottle position (right v. left) was alternated each 
training period to reduce potential bias from place preference. Sucrose preference was calculated 
using the following formula: [Sucrose intake / (water intake + sucrose intake)] × 100. 
  
Statistics 
Data were analyzed independently using SPSS v18 (Chicago, IL). All data were tested for 
normality using the Shapiro-Wilk test. Data not approximating a normal distribution were 
logarithmically transformed before parametric statistical analysis. Intervention (treadmill or 
sedentary) induced differences in BCG-induced sickness behaviors were detected using a 2 
(Treatment = BCG, Saline) x 2 (Intervention = Treadmill, Sedentary) ANOVA, and with 
repeated measures when necessary. Any reference to “groups” implies the following: 
(Saline+Sedentary, Saline+Treadmill, BCG+Sedentary, BCG+Treadmill). Data are expressed as 
mean  SEM. The alpha level was set at p < 0.05 and all tests were two-tailed. 
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Study Design 
 
 
 
6.4 Results 
Baseline Characteristics 
There were no statistically significant pre-intervention differences in body weights between the 
different groups (F3,39=0.72, p=0.549). During days 7-10 of the wheel acclimation period, mice 
ran an average of 3.4 km per day, and there were no differences in daily running distance 
between groups (F3,39=0.97, p=0.419). 
 
Effects of forced treadmill exercise on BCG-induced sickness behaviors: 
Food Intake 
As expected, BCG infection induced a significant reduction in food intake that peaked during the 
initial 24h, and did not return to baseline levels until 7d post-infection (time x treatment: 
F8,280=73.15, p=0.000) (Figure 12).  Forced treadmill exercise did not alter BCG-induced 
anorexia (time x treatment x intervention: F8,280=1.14, p=0.334). There were no differences in 
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food intake between saline injected groups (time x intervention: F8,280=0.88, p=0.534), nor was 
their an intervention main effect (Intervention: F1,35=0.00, p=0.993). 
 
Body weight loss 
As a result of anorexia, all BCG-infected mice lost significant amounts of body weight compared 
to saline treated mice (time x treatment: F8,280=62.65, p=0.000) (Figure 13).  Mice infected with 
BCG that remained sedentary, other than voluntary wheel running, during their recovery 
regained their baseline body weight by 8d post-infection. Interestingly, mice that were forced to 
treadmill exercise daily following BCG infection, exhibited significantly slower body weight 
recovery (time x treatment x intervention F8,280=2.015, p=0.045).  Post-hoc analysis revealed that 
BCG+Treadmill mice exhibited reduced body weight compared to BCG+Sedentary mice at 
every time-point past 24h post-infection. There were no differences in body weight between 
Saline+Treadmill and Saline+Sedentary mice during the study.   
 
Voluntary wheel running 
BCG infected mice significantly reduced their wheel running post-infection compared to saline 
groups, and it never recovered to baseline levels for the duration of the study (time x treatment: 
F8,280=42.78, p=0.000) (Figure 14).  However, BCG-infected mice that were forced to treadmill 
exercise daily exhibited slower VWR recovery compared to BCG-infected mice that were 
allowed to remain sedentary (time x treatment x intervention: F8,280=1.978, p=0.049). Post hoc 
analysis revealed BCG+Treadmill mice exhibited reduced VWR at days 5-7 post-infection 
compared to BCG+Sedentary mice. There were no differences in VWR between 
Saline+Treadmill and Saline+Sedentary mice during the study. 
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Sucrose preference (anhedonia) 
There were no differences in baseline sucrose preference between the four groups prior to BCG-
infection (group: F3,38=0.12, p= 0.049) (Figure 15). At 6d post-infection, BCG-infected mice 
exhibited reduced sucrose preference at compared to Saline treated mice (treatment: F1,35=5.23, 
p= 0.028) . Interestingly, treadmill exercised mice, independent of BCG/Saline exhibited reduced 
sucrose preference compared to sedentary mice (F1,35=4.89, p= 0.034). There was a trend for 
BCG+Treadmill mice to exhibit reduced sucrose preference compared to BCG+Sedentary mice, 
although this did not reach statistical significance (p=0.100). There were no differences  in total 
fluid intake between groups during the sucrose preference testing period. 
 
6.5 Discussion 
We investigated whether forced exercise following BCG infection affects sickness 
behaviors in young adult mice. BCG infection induced significant anorexia, body weight loss, 
anhedonia, and decreased voluntary wheel running compared to saline treated mice.  Mice 
infected with BCG that were forced to treadmill exercise post-infection exhibited protracted 
body weight and voluntary wheel running recovery, and a tendency for exacerbated anhedonia 
compared to BCG-infected mice allowed to remain sedentary post-infection.   
This is the first study to examine forced treadmill exercise post-infection in the context of 
sickness behavior.  Our results support the previously mentioned studies, highlighting the 
necessity of a proper sickness response (i.e., reduced locomotor activity) in animals’ recovery 
from infection [155-157].  However, further insight into forced treadmill running provides an 
alternative interpretation of our data.  Several studies from our lab indicate the ‘forced’ nature of 
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treadmill exercise may be perceived as a stressor by the mice, and induce immunomodulating 
effects.  Lowder et al., demonstrated prolonged treadmill exercise following influenza infection 
increased mouse mortality, which was attributed to an elevated HPA response, and a subsequent 
suppression of immune effector mechanisms [105, 162].  In contrast, Pence et al. found forced 
exercise prior to subcutaneous wounding increased inflammation and speeded wound healing in 
obese mice [163].  Additionally, recent data indicate treadmill exercise, prior to DSS ingestion 
exacerbates, while voluntary wheel running attenuates, DSS induced colitis in mice (unpublished 
data). The interaction between stress and the immune response is complicated, and partially 
based on the timing of the stressor in relation to the immune challenge.  For example, 
inescapable tailshock prior to LPS challenge enhances peripheral and central pro-inflammatory 
cytokine production, indicating stress sensitizes the immune system to subsequent immune 
challenge [164, 165].  Alternatively, stressors applied following immune challenge reduce pro-
inflammatory cytokine expression, virus/bacteria clearance, and increase animal mortality to 
infection.  Goujon et al. demonstrated this phenomenon by subjecting mice to restraint stress 
(RS) immediately following LPS injection, RS mice exhibited significantly lower brain IL-β, 
TNFα, and IL-6 gene expression [166]. Along similar lines, but using a live virus rather than 
bacterial mimetic, Dobbs et al. injected mice with influenza, and then exposed them to six days, 
sixteen minutes per day, of RS [167].  RS significantly reduced influenza virus specific cell 
production of IL-2, IFNγ, and IL-6 from regional lymph node and spleen cells; interestingly, pre-
treatment of the mice with RU486, a type II glucocorticoid receptor antagonist, completely 
abolished the immunosuppressive effects of RS, implicating stress-induced glucocorticoids as 
the primary mediators of this response [167].  Glucocorticoid receptors are capable of 
transrepressing nuclear factor-kappa B (NF-kB) transcriptional activity, which is vital to 
 109 
 
mounting a proper inflammatory response [168]. The dichotomous effect of the timing of stress 
in relationship to immune stressor could be explained by research from several groups, who 
proposed that stress hormones exert a bi-directional effect on immune function [169].   Stress-
induced glucocorticoids sensitize immune cells to a subsequent immune challenge, which results 
in a more robust inflammatory response.  This theory makes sense from an evolutionary 
perspective as stress often precedes wounding/ pathogen entry.  In contrast, stress-induced 
glucocorticoid production following immune challenge acts in an anti-inflammatory fashion and 
suppresses the immune response.  Under this model, stress-induced glucocorticoids re-prioritize 
energy allocation, diverting energy away from the ‘energy intensive’ immune response toward 
the more pressing fight/flight response. While our previous studies have not assessed 
glucocorticoid response to treadmill running, we found that chronic treadmill training induces 
adrenal hypertrophy and thymic atrophy, two classical indicators of stress (unpublished data). 
Furthermore, in the current study, treadmill running reduced sucrose preference in saline treated 
mice, which is a common observation in stressed animals.  Based on these data we speculate 
treadmill running mice immediately post-infection induced an exaggerated HPA and 
glucocorticoid response, which inhibited the initial immune response to BCG, and ultimately 
prolonged BCG clearance and sickness behavior.  This hypothesis is supported by a study from 
Ceddia et al., which found that treadmill exercise following peritoneal thioglycolate 
inflammation reduces macrophage antigen presentation [170, 171]. Unfortunately we did not 
assess BCG-specific cellular immune response, or measure lung BCG colonies, so we can only 
speculate on this theory. 
An alternative explanation for the protracted sickness behaviors observed in 
BCG+Treadmill mice may simply be a matter of energy balance. That is, the energy expended 
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during the treadmill bout may have induced a caloric deficit in BCG-infected mice, leading to 
prolonged weight loss. There were no differences in food intake or body weight between the 
Saline+Treadmill and Saline+Sedentary mice, indicating the daily treadmill exercise bouts did 
not induce energy imbalance healthy mice.  However, as BCG-infected mice significantly 
reduced their food intake post-infection, it is possible treadmill exercise exacerbated this 
anorexia-induced caloric imbalance, and caused prolonged weight loss.  In a similar manner, the 
forced exercise, coupled with exacerbated weight loss, may have altered hypothalamic energy 
sensing in such a way that it induced a reduction in voluntary wheel running in an attempt to 
restore energy homeostasis. Again, as we did not measure energy expenditure or hypothalamic 
energy sensing neurocircuitry, these hypotheses are merely speculation.  
While our study demonstrates forced exercise prolongs certain aspects of BCG-induced 
sickness behavior in young adult mice, we recognize the above-mentioned limitations.  In 
hindsight, we should have collected tissues to assess stress-induced changes in peripheral/brain 
inflammation and immune response to BCG. Additionally, measuring energy expenditure would 
have allowed us to rule out energy balance as a mediator of the treadmill-induced differences 
BCG –induced sickness behaviors.  
In conclusion, this is the first study to demonstrate forced treadmill exercise induces 
protracted sickness responses following BCG infection.  Further research is necessary to 
elucidate the cellular and molecular mechanisms responsible for this effect. From a public health 
perspective, these data support previous research indicating stress (physical and psychological) 
slow recovery from infection, and should be avoided in the post-infection time-period. 
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6.6 Figure Legends and Figures 
 
Figure 12. Effects of treadmill exercise on BCG-induced changes in food intake. BCG 
administration resulted in significant (*) reductions in food intake, but there were no intervention 
main effects or intervention by treatment interactions.  Mean + sem. 
 
Figure 13. Effects of treadmill exercise on BCG-induced in body weight loss. BCG 
administration resulted in a significant (*) reduction in body weight.  BCG+Treadmill mice 
exhibited reduced body weight compared to all other groups at all time-points after 24h (#).  
Mean + sem. 
 
Figure 14. Effects of treadmill exercise on BCG-induced reduction in voluntary wheel 
running. BCG administration resulted in a significant (*) reduction in voluntary wheel running. 
BCG+Treadmill mice exhibited reduced voluntary wheel running compared to all other groups at 
days 6-8 post-infection. (#).  Mean + sem. 
 
Figure 15.  Effects of treadmill exercise on BCG-induced anhedonia. BCG administration 
resulted in a significant (*) reduction in sucrose preference at 6d post-infection. Treadmill 
exercise reduced mouse sucrose preference, independent of BCG/Saline treatment ($).  There 
was a tendency (p=0.10) for BCG+Treadmill mice to exhibit lower sucrose preference compared 
to BCG+Sedentary mice. Mean + sem. 
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CHAPTER 7 
 
CONCLUSIONS 
 
  
Aging of the population and the increased prevalence of chronic diseases among the 
elderly are major challenges facing our society and medical community. Of particular 
importance is the role of age-related neuroinflammation in the etiology of behavioral 
abnormalities following physiological (e.g. immune stimulus) or psychological (e.g. stress) 
challenge.  Aged animals, compared to young animals, display protracted sickness behavior, 
depressive-like behavior, and cognitive impairment after stimulation of the innate immune 
system, and this is related to an exaggerated and prolonged induction of brain inflammation [1-
3]. From a clinical perspective, prolonged sickness behavior and increased depressive symptoms 
result in a reduction in self care, loss of independence, and are often the first steps towards 
dependent living in elderly individuals.  
The overarching aim of these studies was to investigate the effects of voluntary wheel 
training and forced treadmill running on inflammation-induced behavioral disturbances in young 
adult and aged mice.  Our data indicate voluntary wheel training did not attenuate sickness 
behavior or brain proinflammatory cytokine gene expression in old mice. Similarly, voluntary 
wheel training had no effect on lipopolysaccharide-induced depressive-like behavior of brain 
indoleamine 2,3 dioxygenase gene expression in young adult or aged mice.  In contrast, forced 
treadmill exercise post-BCG infection significantly slowed sickness behavior recovery in young 
adult mice. 
Collectively, these data indicate that exercise training provides little protection against 
inflammation-induced behavioral abnormalities, and may actually exacerbate sickness behavior 
if the exercise is perceived as a stressor.  These data contradict a majority of the literature 
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demonstrating a neuroprotective, anti-inflammatory, and anti-depressant effects of exercise.  
Potential explanations for the dichotomous results within the literature include: inflammatory 
model, behavioral outcome, and brain region responsible for observed effect.  Future research 
should examine the effects of exercise on numerous brain regions, and attempt to elucidate the 
regional specificity for the protective effects of exercise. Additionally, understanding how 
exercise affects microglia priming and neuron/microglia communication will provide novel 
insight into the neuroprotective effects regular exercise training. Finally, the animal data needs to 
be translated to human models of aging and sickness. Randomized-controlled clinical trials 
should investigate the effects of regular exercise training prior to, and after infection, on 
perceived sickness behaviors and depression progression in aged adults.   
 
. 
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